Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.
Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.
Measurement of volume of air inhaled or exhaled by the lung.
Analogs or derivatives of scopolamine.
A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
Physiologically, the opposition to flow of air caused by the forces of friction. As a part of pulmonary function testing, it is the ratio of driving pressure to the rate of air flow.
The volume of air that is exhaled by a maximal expiration following a maximal inspiration.
Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR.
An adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
Analogs and derivatives of atropine.
Narrowing of the caliber of the BRONCHI, physiologically or as a result of pharmacological intervention.
Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.
A small aerosol canister used to release a calibrated amount of medication for inhalation.
Drugs that selectively bind to and activate beta-adrenergic receptors.
Any hindrance to the passage of air into and out of the lungs.
Tests involving inhalation of allergens (nebulized or in dust form), nebulized pharmacologically active solutions (e.g., histamine, methacholine), or control solutions, followed by assessment of respiratory function. These tests are used in the diagnosis of asthma.
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.
A variety of devices used in conjunction with METERED DOSE INHALERS. Their purpose is to hold the released medication for inhalation and make it easy for the patients to inhale the metered dose of medication into their lungs.
A histamine H1 antagonist used as the hydrogen fumarate in hay fever, rhinitis, allergic skin conditions, and pruritus. It causes drowsiness.
A quaternary ammonium parasympathomimetic agent with the muscarinic actions of ACETYLCHOLINE. It is hydrolyzed by ACETYLCHOLINESTERASE at a considerably slower rate than ACETYLCHOLINE and is more resistant to hydrolysis by nonspecific CHOLINESTERASES so that its actions are more prolonged. It is used as a parasympathomimetic bronchoconstrictor agent and as a diagnostic aid for bronchial asthma. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1116)
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.
A series of hydrocarbons containing both chlorine and fluorine. These have been used as refrigerants, blowing agents, cleaning fluids, solvents, and as fire extinguishing agents. They have been shown to cause stratospheric ozone depletion and have been banned for many uses.
Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways.
AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives.
The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the TIDAL VOLUME and the INSPIRATORY RESERVE VOLUME. Common abbreviation is IC.
Hospital department which is responsible for the administration of diagnostic pulmonary function tests and of procedures to restore optimum pulmonary ventilation.
The airflow rate measured during the first liter expired after the first 200 ml have been exhausted during a FORCED VITAL CAPACITY determination. Common abbreviations are MEFR, FEF 200-1200, and FEF 0.2-1.2.
Agents that suppress cough. They act centrally on the medullary cough center. EXPECTORANTS, also used in the treatment of cough, act locally.
Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.
Spasmodic contraction of the smooth muscle of the bronchi.
A methyl xanthine derivative from tea with diuretic, smooth muscle relaxant, bronchial dilation, cardiac and central nervous system stimulant activities. Theophylline inhibits the 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE that degrades CYCLIC AMP thus potentiates the actions of agents that act through ADENYLYL CYCLASES and cyclic AMP.
A pyranoquinolone derivative that inhibits activation of inflammatory cells which are associated with ASTHMA, including eosinophils, neutrophils, macrophages, mast cells, monocytes, and platelets.
Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES.
Drugs that are used to treat asthma.
Agents causing the narrowing of the lumen of a bronchus or bronchiole.
Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)
The rate of airflow measured during a FORCED VITAL CAPACITY determination.
Compounds possessing both a hydroxyl (-OH) and an amino group (-NH2).
A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications.
The volume of air remaining in the LUNGS at the end of a normal, quiet expiration. It is the sum of the RESIDUAL VOLUME and the EXPIRATORY RESERVE VOLUME. Common abbreviation is FRC.
A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.
Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.
Adrenal cortex hormones are steroid hormones produced by the outer portion of the adrenal gland, consisting of glucocorticoids, mineralocorticoids, and androgens, which play crucial roles in various physiological processes such as metabolism regulation, stress response, electrolyte balance, and sexual development and function.
Noises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT.
An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.
The hospital unit in which patients with respiratory conditions requiring special attention receive intensive medical care and surveillance.
Butylamines are a class of organic compounds where a butyl group is attached to an amine functional group, with the general structure (C4H9)NHR or (C4H9)NR'R", commonly used as stimulants, entactogens, and psychedelics.
A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi.
Drugs designed to treat inflammation of the nasal passages, generally the result of an infection (more often than not the common cold) or an allergy related condition, e.g., hay fever. The inflammation involves swelling of the mucous membrane that lines the nasal passages and results in inordinate mucus production. The primary class of nasal decongestants are vasoconstrictor agents. (From PharmAssist, The Family Guide to Health and Medicine, 1993)
Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.
Compressed gases or vapors in a container which, upon release of pressure and expansion through a valve, carry another substance from the container. They are used for cosmetics, household cleaners, and so on. Examples are BUTANES; CARBON DIOXIDE; FLUOROCARBONS; NITROGEN; and PROPANE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
The measurement of frequency or oscillation changes.
The total volume of gas inspired or expired per unit of time, usually measured in liters per minute.
The volume of air remaining in the LUNGS at the end of a maximal expiration. Common abbreviation is RV.
Difficult or labored breathing.
A plant genus of the family FABACEAE that contains tephrorin, tephrosone, and C-prenylflavonoids.
A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID.
The volume of air contained in the lungs at the end of a maximal inspiration. It is the equivalent to each of the following sums: VITAL CAPACITY plus RESIDUAL VOLUME; INSPIRATORY CAPACITY plus FUNCTIONAL RESIDUAL CAPACITY; TIDAL VOLUME plus INSPIRATORY RESERVE VOLUME plus functional residual capacity; or tidal volume plus inspiratory reserve volume plus EXPIRATORY RESERVE VOLUME plus residual volume.
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.
Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
Helium. A noble gas with the atomic symbol He, atomic number 2, and atomic weight 4.003. It is a colorless, odorless, tasteless gas that is not combustible and does not support combustion. It was first detected in the sun and is now obtained from natural gas. Medically it is used as a diluent for other gases, being especially useful with oxygen in the treatment of certain cases of respiratory obstruction, and as a vehicle for general anesthetics. (Dorland, 27th ed)
The capability of the LUNGS to distend under pressure as measured by pulmonary volume change per unit pressure change. While not a complete description of the pressure-volume properties of the lung, it is nevertheless useful in practice as a measure of the comparative stiffness of the lung. (From Best & Taylor's Physiological Basis of Medical Practice, 12th ed, p562)
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed)
The relationship between the dose of an administered drug and the response of the organism to the drug.
Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products.
Rapidly decreasing response to a drug or physiologically active agent after administration of a few doses. In immunology, it is the rapid immunization against the effect of toxic doses of an extract or serum by previous injection of small doses. (Dorland, 28th ed)
An amine derived by enzymatic decarboxylation of HISTIDINE. It is a powerful stimulant of gastric secretion, a constrictor of bronchial smooth muscle, a vasodilator, and also a centrally acting neurotransmitter.
Use of written, printed, or graphic materials upon or accompanying a drug container or wrapper. It includes contents, indications, effects, dosages, routes, methods, frequency and duration of administration, warnings, hazards, contraindications, side effects, precautions, and other relevant information.
A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.
A plant genus, in the family AMARANTHACEAE, best known as a source of high-protein grain crops and of Red Dye No. 2 (AMARANTH DYE). Tumbleweed sometimes refers to Amaranthus but more often refers to SALSOLA.
Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available.
Therapy with two or more separate preparations given for a combined effect.
A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic (more than 3 months in 2 consecutive years) productive cough. Infectious agents are a major cause of chronic bronchitis.
A long-acting beta-2-adrenergic receptor agonist.
Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only.
Asthma attacks following a period of exercise. Usually the induced attack is short-lived and regresses spontaneously. The magnitude of postexertional airway obstruction is strongly influenced by the environment in which exercise is performed (i.e. inhalation of cold air during physical exertion markedly augments the severity of the airway obstruction; conversely, warm humid air blunts or abolishes it).
Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
A phenethylamine found in EPHEDRA SINICA. PSEUDOEPHEDRINE is an isomer. It is an alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used for asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists.
A racemic mixture of d-epinephrine and l-epinephrine.
Measurement of the volume of gas in the lungs, including that which is trapped in poorly communicating air spaces. It is of particular use in chronic obstructive pulmonary disease and emphysema. (Segen, Dictionary of Modern Medicine, 1992)
Barriers used to separate and remove PARTICULATE MATTER from air.
Measurement of the amount of air that the lungs may contain at various points in the respiratory cycle.
A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level.
2-Octylcyclopentaneheptanoic acids. The family of saturated carbon-20 cyclic fatty acids that represent the parent compounds of the prostaglandins.
Medicines that can be sold legally without a DRUG PRESCRIPTION.
Elements of limited time intervals, contributing to particular results or situations.
Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol.
Inflammation of the BRONCHIOLES.
A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The adrenergic beta-2 receptors are more sensitive to EPINEPHRINE than to NOREPINEPHRINE and have a high affinity for the agonist TERBUTALINE. They are widespread, with clinically important roles in SKELETAL MUSCLE; LIVER; and vascular, bronchial, gastrointestinal, and genitourinary SMOOTH MUSCLE.
The extra volume of air that can be expired with maximum effort beyond the level reached at the end of a normal, quiet expiration. Common abbreviation is ERV.
Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
A plant genus of the family MYRTACEAE. Members contain PHYTOHEMAGGLUTININS.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.
Physiological processes and properties of the RESPIRATORY SYSTEM as a whole or of any of its parts.
Recording of change in the size of a part as modified by the circulation in it.
Disease having a short and relatively severe course.
A sulfur-containing alkyl thionitrite that is one of the NITRIC OXIDE DONORS.
Inhalation of oxygen aimed at restoring toward normal any pathophysiologic alterations of gas exchange in the cardiopulmonary system, as by the use of a respirator, nasal catheter, tent, chamber, or mask. (From Dorland, 27th ed & Stedman, 25th ed)
A group of compounds that are derivatives of beta-methylacetylcholine (methacholine).
Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.
Compounds that specifically inhibit PHOSPHODIESTERASE 4.
Pyridines substituted in any position with an amino group. May be hydrogenated, but must retain at least one double bond.
The act of breathing with the LUNGS, consisting of INHALATION, or the taking into the lungs of the ambient air, and of EXHALATION, or the expelling of the modified air which contains more CARBON DIOXIDE than the air taken in (Blakiston's Gould Medical Dictionary, 4th ed.). This does not include tissue respiration (= OXYGEN CONSUMPTION) or cell respiration (= CELL RESPIRATION).
A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Systems designed to provide information primarily concerned with the administrative functions associated with the provision and utilization of services; also includes program planning, etc.
The physical or mechanical action of the LUNGS; DIAPHRAGM; RIBS; and CHEST WALL during respiration. It includes airflow, lung volume, neural and reflex controls, mechanoreceptors, breathing patterns, etc.
Hypersensitivity reactions which occur within minutes of exposure to challenging antigen due to the release of histamine which follows the antigen-antibody reaction and causes smooth muscle contraction and increased vascular permeability.
Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed)
Application of positive pressure to the inspiratory phase of spontaneous respiration.
Cyclopropanes are a class of hydrocarbons characterized by a small ring structure containing three carbon atoms, each with single bonds to the other two carbons and to hydrogen atoms, making it highly strained and reactive, which has implications for its use as an anesthetic in medicine.
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases.

Kinetic analysis of drug-receptor interactions of long-acting beta2 sympathomimetics in isolated receptor membranes: evidence against prolonged effects of salmeterol and formoterol on receptor-coupled adenylyl cyclase. (1/2342)

The long-acting beta2 sympathomimetics salmeterol and formoterol have been presumed to exert their prolonged action either by binding to an accessory binding site ("exo-site") near the beta2 adrenoceptor or by their high affinity for beta2 adrenoceptors and correspondingly slow dissociation. Whereas most studies with salmeterol had been done in intact tissues, which have slow diffusion and compartmentation of drugs in lipophilic phases, that restrict drug access to the receptor biophase, we used purified receptor membranes from rat lung and disaggregated calf tracheal myocytes as model systems. Binding experiments were designed to measure the slow dissociation of agonists by means of delayed association of (-)-[125I]iodopindolol. Rat lung membranes were pretreated with high concentrations of agonists (salmeterol, formoterol, isoprenaline) before dissociation was induced by 50-fold dilution. Half-times of association of (-)-[125I]iodopindolol remained unchanged compared with untreated controls, indicating that dissociation of agonists occurred in less than 2 min. Adenylyl cyclase experiments were designed to determine the on and off kinetics of agonists to beta2 adrenoceptors by measuring the rate of receptor-induced cyclic AMP (cAMP) formation. Experiments were performed in tracheal membranes characterized by high Vmax values of cAMP formation. Adenylyl cyclase activation occurred simultaneously with the addition of the agonist, continued linearly with time for 60 min, and ceased immediately after the antagonist was added. Similarly, when receptor membranes were preincubated in a small volume with high salmeterol concentrations, there was a linear increase in cAMP formation, which was immediately interrupted by a 100-fold dilution of the reaction mixture. This militates against the exo-site hypothesis. On the other hand, dissociation by dilution was much less when membranes were preincubated with a large volume of salmeterol at the same concentration, indicating that physicochemical effects, and not exo-site binding, underlie its prolonged mode of action.  (+info)

Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy. (2/2342)

The aim of the present study was to investigate bronchoprotective sensitivity in patients receiving regular treatment with short- and long-acting beta2-agonists and to evaluate any possible association with genetic polymorphism. Thirty-eight patients with stable mild to moderate asthma and receiving inhaled corticosteroids were randomized in a parallel group, double-blind, double-dummy fashion to receive 2 weeks of treatment with either formoterol (12 microg once daily, 6 microg twice daily or 24 microg twice daily) or terbutaline (500 microg four times daily). Bronchoprotection against methacholine challenge (as a provocative dose to produce a 20% fall in forced expiratory volume in 1.0 s: PD20) was measured at baseline (unprotected) after an initial 1 week run-in without beta2-agonist, and at 1 h after the first and last doses of each treatment. The PD20 values were log-transformed and calculated as change from baseline. Percentage desensitization of log PD20 for first- versus last-dose bronchoprotection was calculated and analysed according to effects of treatment and beta2-adrenoceptor polymorphism at codon 16 or 27. The mean degree of desensitization for bronchoprotection was comparable with all four treatments and there were no significant differences in absolute PD20 values after 2 weeks of chronic dosing. The PD20 values were (as microg of methacholine, geometric means+/-S. E.M.): formoterol, 12 microg once daily, 99+/-42 microg; formoterol, 6 microg twice daily, 107+/-44 microg; formoterol, 24 microg twice daily, 108+/-45 microg; terbutaline, 500 microg four times daily, 88+/-37 microg. All patients receiving formoterol, 24 microg twice daily, exhibited a loss of protection greater than 30% which was unrelated to polymorphism at codon 16 or 27. For codon 16, the use of lower doses of formoterol (12 microg once daily or 6 microg twice daily) showed wider variability in the propensity for protection loss in patients who were heterozygous, in contrast to a more uniform protection loss seen with homozygous glycine patients. The amount of protection loss was not significantly related to polymorphism at codon 16 or 27, expressed as values (mean+/-S.E.M.) for percentage desensitization according to each genotype (pooled treatments): Gly-16, 66+/-11%; Het-16, 53+/-8%; Arg-16, 69+/-18%; Glu-27, 68+/-12%; Het-27, 58+/-8%; Gln-27, 52+/-12%. The results of this preliminary study showed that bronchoprotective desensitization occurred readily in response to short- or long-acting beta2-agonist exposure irrespective of beta2-adrenoceptor polymorphism at codon 16 or 27. Further studies with larger patient numbers are required to further evaluate the effects of polymorphisms with lower doses of regular formoterol.  (+info)

Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholine. (3/2342)

1. Immunized BP2 mice developed an acute bronchoconstriction in vivo and airway muscle contraction in vitro in response to ovalbumin (OA) and these contractions were dose dependent. 2. Methysergide or atropine inhibited OA-induced bronchoconstriction in vivo and airway muscle contraction in vitro. 3. Neostigmine potentiated the OA-induced bronchoconstriction in vivo and airway muscle contraction in vitro of BP2 mice. This potentiation was markedly reduced by the administration of methysergide or atropine and when the two antagonists were administered together, the responses were completely inhibited. 4. Neostigmine also potentiated the serotonin (5-HT)- and acetylcholine (ACh)-induced bronchoconstriction and this potentiation was significantly reversed by atropine. 5. These results indicate that OA provokes a bronchoconstriction in immunized BP2 mice by stimulating the release of 5-HT, which in turn acts via the cholinergic mediator, ACh.  (+info)

Nitrogen dioxide formation during inhaled nitric oxide therapy. (4/2342)

BACKGROUND: Nitrogen dioxide (NO2) is a toxic by-product of inhalation therapy with nitric oxide (NO). The rate of NO2 formation during NO therapy is controversial. METHODS: The formation of NO2 was studied under dynamic flows emulating a base case NO ventilator mixture containing 80 ppm NO in a 90% oxygen matrix. The difficulty in measuring NO2 concentrations below 2 ppm accurately was overcome by the use of tunable diode laser absorption spectroscopy. RESULTS: Using a second-order model, the rate constant, k, for NO2 formation was determined to be (1.19 +/- 0.11) x 10(-11) ppm-2s-1, which is in basic agreement with evaluated data from atmospheric literature. CONCLUSIONS: Inhaled NO can be delivered safely in a well-designed, continuous flow neonatal ventilatory circuit, and NO2 formation can be calculated reliably using the rate constant and circuit dwell time.  (+info)

The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects. (5/2342)

Salmeterol is approximately eight times as potent as salbutamol for systemic effects. This may be because the drug is eight times more potent on receptors or there may be differences in systemic bioavailability. The systemic effects of salbutamol are limited by its fairly high first-pass metabolism, but the oral bioavailability of salmeterol is unknown. The contribution of the swallowed fraction of an inhaled dose of salmeterol to its systemic effects were analysed in a randomized, double-blind, crossover study. Twelve healthy subjects were given inhaled salmeterol 400 microg, inhaled salmeterol 400 microg plus oral activated charcoal or inhaled placebo plus oral activated charcoal on three separate days. Cardiac frequency (fC), Q-T interval corrected for heart rate (QTc), plasma potassium and glucose concentrations were measured for 4 h following the inhaled drug. Salmeterol with and without oral charcoal produced significant changes for all measures compared to placebo. The magnitude of effect following salmeterol alone was significantly greater than that following salmeterol plus charcoal for fC and glucose (mean (95% confidence interval) differences 8 (2-13) beats x min(-1), 0.59 (0.04, 1.13) mmol x L(-1), respectively) and nonsignificantly greater for QTc interval and potassium concentration. The differences between salmeterol given with and without charcoal suggest that 28-36% of the systemic response to salmeterol administered from a metered-dose inhaler are due to drug absorbed from the gastrointestinal tract. Thus, most of the systemic effects are due to the inhaled fraction of the drug.  (+info)

Time course of respiratory decompensation in chronic obstructive pulmonary disease: a prospective, double-blind study of peak flow changes prior to emergency department visits. (6/2342)

The aim of this study was to look at changes in peak expiratory flow rates (PEFR) prior to emergency department visits for decompensated chronic obstructive pulmonary disease (COPD). It was designed as a prospective, double-blind study at the Albuquerque Veterans Affairs Medical Center. Twelve patients with an irreversible component of airflow obstruction on pulmonary function tests were assessed. At entry, all subjects were instructed in the use of a mini-Wright peak flow meter with electronic data storage. They then entered a 6-month monitoring phase in which they recorded PEFR twice daily, before and after bronchodilators. The meter displays were disabled so that the patients and their physicians were blinded to all values. Medical care was provided in the customary manner. Patients were considered to have respiratory decompensation if they required treatment for airflow obstruction in the Emergency Department (ED) and no other causes of dyspnea could be identified. Simple linear regression was used to model changes in PEFR over time. The 12 subjects had 22 episodes of respiratory decompensation during 1741 patient-days of observation. Two episodes could not be analysed because of missing values. Ten episodes in seven subjects were characterized by a significant linear decline in at least one peak flow parameter prior to presentation. The mean rates of change for the four daily parameters varied from 0.22% to 0.27% predicted per day (or 1.19 to 1.44 1 min-1 day-1). The average decrement in these parameters ranged from 30.0 to 33.8 1 min-1 (or 18.6%-25.9% of their baseline values). No temporal trends were found for the 10 episodes occurring in the other five subjects. We concluded that respiratory decompensation is characterized by a gradual decline in PEFR in about half of cases. Future studies should be done to elucidate the mechanisms of respiratory distress in the other cases.  (+info)

Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing. (7/2342)

BACKGROUND: Previous studies suggest that recurrent episodes of coughing and wheezing occur in up to 75% of infants after acute viral bronchiolitis. AIM: To assess the efficacy of budesonide given by means of a metered dose inhaler, spacer, and face mask in reducing the incidence of coughing and wheezing episodes up to 12 months after acute viral bronchiolitis. METHODS: Children under the age of 12 months admitted to hospital with acute viral bronchiolitis were randomised to receive either budesonide or placebo (200 microg or one puff twice daily) for the next eight weeks. Parents kept a diary card record of all episodes of coughing and wheezing over the next 12 months. RESULTS: Full follow up data were collected for 49 infants. There were no significant differences between the two study groups for the number of infants with symptom episodes up to six months after hospital discharge. At 12 months, 21 infants in the budesonide group had symptom episodes compared with 12 of 24 in the placebo group. The median number of symptom episodes was 2 (range, 0-13) in those who received budesonide and 1 (range, 0-11) in those who received placebo. Because there is no pharmacological explanation for these results, they are likely to be caused by a type 1 error, possibly exacerbated by there being more boys in the treatment group. CONCLUSION: Routine administration of budesonide by means of a metered dose inhaler, spacer, and face mask system immediately after acute viral bronchiolitis cannot be recommended.  (+info)

Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma. (8/2342)

BACKGROUND: Patients with asthma have an increased risk of death from causes other than asthma. A study was undertaken to identify whether severity of asthma, its treatment, or associated co-morbidity were associated with increased risk of death from other causes. METHODS: Eighty five deaths from all causes occurring within three years of discharge from hospital in a cohort of 2242 subjects aged 16-64 years admitted for asthma were compared with a random sample of 61 controls aged <45 years and 61 aged >/=45 years from the same cohort. RESULTS: Deaths from asthma were associated with a history of clinically severe asthma (OR 6.29 (95% CI 1.84 to 21.52)), chest pain (OR 3.78 (95% CI 1.06 to 13.5)), biochemical or haematological abnormalities at admission (OR 4.12 (95% CI 1.36 to 12.49)), prescription of ipratropium bromide (OR 4.04 (95% CI 1.47 to 11.13)), and failure to prescribe inhaled steroids on discharge (OR 3.45 (95% CI 1.35 to 9.10)). Deaths from chronic obstructive pulmonary disease (COPD) were associated with lower peak expiratory flow rates (OR 2.56 (95% CI 1.52 to 4.35) for each 50 l/min change), a history of smoking (OR 5.03 (95% CI 1.17 to 21.58)), prescription of ipratropium bromide (OR 7.75 (95% CI 2.21 to 27.14)), and failure to prescribe inhaled steroids on discharge (OR 3.33 (95% CI 0.95 to 11.10)). Cardiovascular deaths were more common among those prescribed ipratropium bromide on discharge (OR 3.55 (95% CI 1.05 to 11.94)) and less likely in those admitted after an upper respiratory tract infection (OR 0.21 (95% CI 0.05 to 0.95)). Treatment with ipratropium bromide at discharge was associated with an increased risk of death from asthma even after adjusting for peak flow, COPD and cardiovascular co-morbidity, ever having smoked, and age at onset of asthma. CONCLUSIONS: Prescription of inhaled steroids on discharge is important even for those patients with co-existent COPD and asthma. Treatment with ipratropium at discharge is associated with increased risk of death from asthma even after adjustment for a range of markers of COPD. These results need to be tested in larger studies.  (+info)

Bronchodilators are medications that relax and widen the airways (bronchioles) in the lungs, making it easier to breathe. They work by relaxing the smooth muscle around the airways, which allows them to dilate or open up. This results in improved airflow and reduced symptoms of bronchoconstriction, such as wheezing, coughing, and shortness of breath.

Bronchodilators can be classified into two main types: short-acting and long-acting. Short-acting bronchodilators are used for quick relief of symptoms and last for 4 to 6 hours, while long-acting bronchodilators are used for maintenance therapy and provide symptom relief for 12 hours or more.

Examples of bronchodilator agents include:

* Short-acting beta-agonists (SABAs) such as albuterol, levalbuterol, and pirbuterol
* Long-acting beta-agonists (LABAs) such as salmeterol, formoterol, and indacaterol
* Anticholinergics such as ipratropium, tiotropium, and aclidinium
* Combination bronchodilators that contain both a LABA and an anticholinergic, such as umeclidinium/vilanterol and glycopyrrolate/formoterol.

Albuterol is a medication that is used to treat bronchospasm, or narrowing of the airways in the lungs, in conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is a short-acting beta-2 agonist, which means it works by relaxing the muscles around the airways, making it easier to breathe. Albuterol is available in several forms, including an inhaler, nebulizer solution, and syrup, and it is typically used as needed to relieve symptoms of bronchospasm. It may also be used before exercise to prevent bronchospasm caused by physical activity.

The medical definition of Albuterol is: "A short-acting beta-2 adrenergic agonist used to treat bronchospasm in conditions such as asthma and COPD. It works by relaxing the muscles around the airways, making it easier to breathe."

Ipratropium is an anticholinergic bronchodilator medication that is often used to treat respiratory conditions such as chronic obstructive pulmonary disease (COPD) and asthma. It works by blocking the action of acetylcholine, a chemical messenger in the body that causes muscles around the airways to tighten and narrow. By preventing this effect, ipratropium helps to relax the muscles around the airways, making it easier to breathe.

Ipratropium is available in several forms, including an aerosol spray, nebulizer solution, and dry powder inhaler. It is typically used in combination with other respiratory medications, such as beta-agonists or corticosteroids, to provide more effective relief of symptoms. Common side effects of ipratropium include dry mouth, throat irritation, and headache.

Forced Expiratory Volume (FEV) is a medical term used to describe the volume of air that can be forcefully exhaled from the lungs in one second. It is often measured during pulmonary function testing to assess lung function and diagnose conditions such as chronic obstructive pulmonary disease (COPD) or asthma.

FEV is typically expressed as a percentage of the Forced Vital Capacity (FVC), which is the total volume of air that can be exhaled from the lungs after taking a deep breath in. The ratio of FEV to FVC is used to determine whether there is obstruction in the airways, with a lower ratio indicating more severe obstruction.

There are different types of FEV measurements, including FEV1 (the volume of air exhaled in one second), FEV25-75 (the average volume of air exhaled during the middle 50% of the FVC maneuver), and FEV0.5 (the volume of air exhaled in half a second). These measurements can provide additional information about lung function and help guide treatment decisions.

Asthma is a chronic respiratory disease characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, coughing, shortness of breath, and chest tightness. The airway obstruction in asthma is usually reversible, either spontaneously or with treatment.

The underlying cause of asthma involves a combination of genetic and environmental factors that result in hypersensitivity of the airways to certain triggers, such as allergens, irritants, viruses, exercise, and emotional stress. When these triggers are encountered, the airways constrict due to smooth muscle spasm, swell due to inflammation, and produce excess mucus, leading to the characteristic symptoms of asthma.

Asthma is typically managed with a combination of medications that include bronchodilators to relax the airway muscles, corticosteroids to reduce inflammation, and leukotriene modifiers or mast cell stabilizers to prevent allergic reactions. Avoiding triggers and monitoring symptoms are also important components of asthma management.

There are several types of asthma, including allergic asthma, non-allergic asthma, exercise-induced asthma, occupational asthma, and nocturnal asthma, each with its own set of triggers and treatment approaches. Proper diagnosis and management of asthma can help prevent exacerbations, improve quality of life, and reduce the risk of long-term complications.

Terbutaline is a medication that belongs to a class of drugs called beta-2 adrenergic agonists. It works by relaxing muscles in the airways and increasing the flow of air into the lungs, making it easier to breathe. Terbutaline is used to treat bronchospasm (wheezing, shortness of breath) associated with asthma, chronic bronchitis, emphysema, and other lung diseases. It may also be used to prevent or treat bronchospasm caused by exercise or to prevent premature labor in pregnant women.

The medical definition of Terbutaline is: "A synthetic sympathomimetic amine used as a bronchodilator for the treatment of asthma, bronchitis, and emphysema. It acts as a nonselective beta-2 adrenergic agonist, relaxing smooth muscle in the airways and increasing airflow to the lungs."

"Inhalation administration" is a medical term that refers to the method of delivering medications or therapeutic agents directly into the lungs by inhaling them through the airways. This route of administration is commonly used for treating respiratory conditions such as asthma, COPD (chronic obstructive pulmonary disease), and cystic fibrosis.

Inhalation administration can be achieved using various devices, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, and soft-mist inhalers. Each device has its unique mechanism of delivering the medication into the lungs, but they all aim to provide a high concentration of the drug directly to the site of action while minimizing systemic exposure and side effects.

The advantages of inhalation administration include rapid onset of action, increased local drug concentration, reduced systemic side effects, and improved patient compliance due to the ease of use and non-invasive nature of the delivery method. However, proper technique and device usage are crucial for effective therapy, as incorrect usage may result in suboptimal drug deposition and therapeutic outcomes.

Nebulizer: A nebulizer is a medical device that delivers medication in the form of a mist to the respiratory system. It is often used for people who have difficulty inhaling medication through traditional inhalers, such as young children or individuals with severe respiratory conditions. The medication is placed in the nebulizer cup and then converted into a fine mist by the machine. This allows the user to breathe in the medication directly through a mouthpiece or mask.

Vaporizer: A vaporizer, on the other hand, is a device that heats up a liquid, often water or essential oils, to produce steam or vapor. While some people use vaporizers for therapeutic purposes, such as to help relieve congestion or cough, it is important to note that vaporizers are not considered medical devices and their effectiveness for these purposes is not well-established.

It's worth noting that nebulizers and vaporizers are different from each other in terms of their purpose and usage. Nebulizers are used specifically for delivering medication, while vaporizers are used to produce steam or vapor, often for non-medical purposes.

Spirometry is a common type of pulmonary function test (PFT) that measures how well your lungs work. This is done by measuring how much air you can exhale from your lungs after taking a deep breath, and how quickly you can exhale it. The results are compared to normal values for your age, height, sex, and ethnicity.

Spirometry is used to diagnose and monitor certain lung conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and other respiratory diseases that cause narrowing of the airways. It can also be used to assess the effectiveness of treatment for these conditions. The test is non-invasive, safe, and easy to perform.

Scopolamine derivatives are a class of compounds that are chemically related to scopolamine, a natural alkaloid found in certain plants such as nightshade. These derivatives share similar structural and pharmacological properties with scopolamine, which is a muscarinic antagonist. They block the action of acetylcholine, a neurotransmitter, at muscarinic receptors in the nervous system.

Scopolamine derivatives are commonly used in medical settings as anticholinergics, which have various therapeutic applications. They can be used to treat conditions such as motion sickness, nausea and vomiting, Parkinson's disease, and certain types of nerve agent poisoning. Some examples of scopolamine derivatives include hyoscine, pirenzepine, and telenzepine.

It is important to note that scopolamine derivatives can have significant side effects, including dry mouth, blurred vision, dizziness, and cognitive impairment. Therefore, they should be used with caution and under the close supervision of a healthcare provider.

Metaproterenol is a short-acting, selective beta-2 adrenergic receptor agonist. It is primarily used as a bronchodilator to treat and prevent bronchospasms associated with reversible obstructive airway diseases such as asthma, chronic bronchitis, and emphysema. Metaproterenol works by relaxing the smooth muscles in the airways, thereby opening up the air passages and making it easier to breathe. It is available in oral (tablet or liquid) and inhalation (aerosol or solution for nebulization) forms. Common side effects include tremors, nervousness, headache, tachycardia, and palpitations.

Airway resistance is a measure of the opposition to airflow during breathing, which is caused by the friction between the air and the walls of the respiratory tract. It is an important parameter in respiratory physiology because it can affect the work of breathing and gas exchange.

Airway resistance is usually expressed in units of cm H2O/L/s or Pa·s/m, and it can be measured during spontaneous breathing or during forced expiratory maneuvers, such as those used in pulmonary function testing. Increased airway resistance can result from a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and bronchiectasis. Decreased airway resistance can be seen in conditions such as emphysema or after a successful bronchodilator treatment.

Vital capacity (VC) is a term used in pulmonary function tests to describe the maximum volume of air that can be exhaled after taking a deep breath. It is the sum of inspiratory reserve volume, tidal volume, and expiratory reserve volume. In other words, it's the total amount of air you can forcibly exhale after inhaling as deeply as possible. Vital capacity is an important measurement in assessing lung function and can be reduced in conditions such as chronic obstructive pulmonary disease (COPD), asthma, and other respiratory disorders.

Peak Expiratory Flow Rate (PEFR) is a measurement of how quickly a person can exhale air from their lungs. It is often used as a quick test to assess breathing difficulties in people with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). PEFR is measured in liters per minute (L/min) and the highest value obtained during a forceful exhalation is recorded as the peak expiratory flow rate. Regular monitoring of PEFR can help to assess the severity of an asthma attack or the effectiveness of treatment.

Fenoterol is a short-acting β2-adrenergic receptor agonist, which is a type of medication used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles in the airways and increasing the flow of air into the lungs, making it easier to breathe.

Fenoterol is available in various forms, including inhalation solution, nebulizer solution, and dry powder inhaler. It is usually used as a rescue medication to relieve sudden symptoms or during an asthma attack. Like other short-acting β2-agonists, fenoterol has a rapid onset of action but its effects may wear off quickly, typically within 4-6 hours.

It is important to note that the use of fenoterol has been associated with an increased risk of severe asthma exacerbations and cardiovascular events, such as irregular heartbeat and high blood pressure. Therefore, it should be used with caution and only under the supervision of a healthcare professional.

Obstructive lung disease is a category of respiratory diseases characterized by airflow limitation that causes difficulty in completely emptying the alveoli (tiny air sacs) of the lungs during exhaling. This results in the trapping of stale air and prevents fresh air from entering the alveoli, leading to various symptoms such as coughing, wheezing, shortness of breath, and decreased exercise tolerance.

The most common obstructive lung diseases include:

1. Chronic Obstructive Pulmonary Disease (COPD): A progressive disease that includes chronic bronchitis and emphysema, often caused by smoking or exposure to harmful pollutants.
2. Asthma: A chronic inflammatory disorder of the airways characterized by variable airflow obstruction, bronchial hyperresponsiveness, and an underlying inflammation. Symptoms can be triggered by various factors such as allergens, irritants, or physical activity.
3. Bronchiectasis: A condition in which the airways become abnormally widened, scarred, and thickened due to chronic inflammation or infection, leading to mucus buildup and impaired clearance.
4. Cystic Fibrosis: An inherited genetic disorder that affects the exocrine glands, resulting in thick and sticky mucus production in various organs, including the lungs. This can lead to chronic lung infections, inflammation, and airway obstruction.
5. Alpha-1 Antitrypsin Deficiency: A genetic condition characterized by low levels of alpha-1 antitrypsin protein, which leads to uncontrolled protease enzyme activity that damages the lung tissue, causing emphysema-like symptoms.

Treatment for obstructive lung diseases typically involves bronchodilators (to relax and widen the airways), corticosteroids (to reduce inflammation), and lifestyle modifications such as smoking cessation and pulmonary rehabilitation programs. In severe cases, oxygen therapy or even lung transplantation may be considered.

Atropine derivatives are a class of drugs that are chemically related to atropine, an alkaloid found in the nightshade family of plants. These drugs have anticholinergic properties, which means they block the action of the neurotransmitter acetylcholine in the body.

Atropine derivatives can be used for a variety of medical purposes, including:

1. Treating motion sickness and vertigo
2. Dilating the pupils during eye examinations
3. Reducing saliva production during surgical procedures
4. Treating certain types of poisoning, such as organophosphate or nerve gas poisoning
5. Managing symptoms of some neurological disorders, such as Parkinson's disease and myasthenia gravis

Some examples of atropine derivatives include hyoscyamine, scopolamine, and ipratropium. These drugs can have side effects, including dry mouth, blurred vision, constipation, difficulty urinating, and rapid heartbeat. They should be used with caution and under the supervision of a healthcare provider.

Bronchoconstriction is a medical term that refers to the narrowing of the airways in the lungs (the bronchi and bronchioles) due to the contraction of the smooth muscles surrounding them. This constriction can cause difficulty breathing, wheezing, coughing, and shortness of breath, which are common symptoms of asthma and other respiratory conditions.

Bronchoconstriction can be triggered by a variety of factors, including allergens, irritants, cold air, exercise, and emotional stress. In some cases, it may also be caused by certain medications, such as beta-blockers or nonsteroidal anti-inflammatory drugs (NSAIDs). Treatment for bronchoconstriction typically involves the use of bronchodilators, which are medications that help to relax the smooth muscles around the airways and widen them, making it easier to breathe.

Respiratory Function Tests (RFTs) are a group of medical tests that measure how well your lungs take in and exhale air, and how well they transfer oxygen and carbon dioxide into and out of your blood. They can help diagnose certain lung disorders, measure the severity of lung disease, and monitor response to treatment.

RFTs include several types of tests, such as:

1. Spirometry: This test measures how much air you can exhale and how quickly you can do it. It's often used to diagnose and monitor conditions like asthma, chronic obstructive pulmonary disease (COPD), and other lung diseases.
2. Lung volume testing: This test measures the total amount of air in your lungs. It can help diagnose restrictive lung diseases, such as pulmonary fibrosis or sarcoidosis.
3. Diffusion capacity testing: This test measures how well oxygen moves from your lungs into your bloodstream. It's often used to diagnose and monitor conditions like pulmonary fibrosis, interstitial lung disease, and other lung diseases that affect the ability of the lungs to transfer oxygen to the blood.
4. Bronchoprovocation testing: This test involves inhaling a substance that can cause your airways to narrow, such as methacholine or histamine. It's often used to diagnose and monitor asthma.
5. Exercise stress testing: This test measures how well your lungs and heart work together during exercise. It's often used to diagnose lung or heart disease.

Overall, Respiratory Function Tests are an important tool for diagnosing and managing a wide range of lung conditions.

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by the persistent obstruction of airflow in and out of the lungs. This obstruction is usually caused by two primary conditions: chronic bronchitis and emphysema. Chronic bronchitis involves inflammation and narrowing of the airways, leading to excessive mucus production and coughing. Emphysema is a condition where the alveoli (air sacs) in the lungs are damaged, resulting in decreased gas exchange and shortness of breath.

The main symptoms of COPD include progressive shortness of breath, chronic cough, chest tightness, wheezing, and excessive mucus production. The disease is often associated with exposure to harmful particles or gases, such as cigarette smoke, air pollution, or occupational dusts and chemicals. While there is no cure for COPD, treatments can help alleviate symptoms, improve quality of life, and slow the progression of the disease. These treatments may include bronchodilators, corticosteroids, combination inhalers, pulmonary rehabilitation, and, in severe cases, oxygen therapy or lung transplantation.

Aerosols are defined in the medical field as suspensions of fine solid or liquid particles in a gas. In the context of public health and medicine, aerosols often refer to particles that can remain suspended in air for long periods of time and can be inhaled. They can contain various substances, such as viruses, bacteria, fungi, or chemicals, and can play a role in the transmission of respiratory infections or other health effects.

For example, when an infected person coughs or sneezes, they may produce respiratory droplets that can contain viruses like influenza or SARS-CoV-2 (the virus that causes COVID-19). Some of these droplets can evaporate quickly and leave behind smaller particles called aerosols, which can remain suspended in the air for hours and potentially be inhaled by others. This is one way that respiratory viruses can spread between people in close proximity to each other.

Aerosols can also be generated through medical procedures such as bronchoscopy, suctioning, or nebulizer treatments, which can produce aerosols containing bacteria, viruses, or other particles that may pose an infection risk to healthcare workers or other patients. Therefore, appropriate personal protective equipment (PPE) and airborne precautions are often necessary to reduce the risk of transmission in these settings.

A Metered Dose Inhaler (MDI) is a medical device used to administer a specific amount or "metered dose" of medication, usually in the form of an aerosol, directly into the lungs of a patient. The MDI consists of a pressurized canister that contains the medication mixed with a propellant, a metering valve that releases a precise quantity of the medication, and a mouthpiece or mask for the patient to inhale the medication.

MDIs are commonly used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. They are also used to deliver other medications such as corticosteroids, anticholinergics, and beta-agonists. Proper use of an MDI requires coordination between the pressing of the canister and inhalation of the medication, which may be challenging for some patients. Therefore, it is essential to receive proper training on how to use an MDI effectively.

Adrenergic beta-agonists are a class of medications that bind to and activate beta-adrenergic receptors, which are found in various tissues throughout the body. These receptors are part of the sympathetic nervous system and mediate the effects of the neurotransmitter norepinephrine (also called noradrenaline) and the hormone epinephrine (also called adrenaline).

When beta-agonists bind to these receptors, they stimulate a range of physiological responses, including relaxation of smooth muscle in the airways, increased heart rate and contractility, and increased metabolic rate. As a result, adrenergic beta-agonists are often used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis, as they can help to dilate the airways and improve breathing.

There are several different types of beta-agonists, including short-acting and long-acting formulations. Short-acting beta-agonists (SABAs) are typically used for quick relief of symptoms, while long-acting beta-agonists (LABAs) are used for more sustained symptom control. Examples of adrenergic beta-agonists include albuterol (also known as salbutamol), terbutaline, formoterol, and salmeterol.

It's worth noting that while adrenergic beta-agonists can be very effective in treating respiratory conditions, they can also have side effects, particularly if used in high doses or for prolonged periods of time. These may include tremors, anxiety, palpitations, and increased blood pressure. As with any medication, it's important to use adrenergic beta-agonists only as directed by a healthcare professional.

Airway obstruction is a medical condition that occurs when the normal flow of air into and out of the lungs is partially or completely blocked. This blockage can be caused by a variety of factors, including swelling of the tissues in the airway, the presence of foreign objects or substances, or abnormal growths such as tumors.

When the airway becomes obstructed, it can make it difficult for a person to breathe normally. They may experience symptoms such as shortness of breath, wheezing, coughing, and chest tightness. In severe cases, airway obstruction can lead to respiratory failure and other life-threatening complications.

There are several types of airway obstruction, including:

1. Upper airway obstruction: This occurs when the blockage is located in the upper part of the airway, such as the nose, throat, or voice box.
2. Lower airway obstruction: This occurs when the blockage is located in the lower part of the airway, such as the trachea or bronchi.
3. Partial airway obstruction: This occurs when the airway is partially blocked, allowing some air to flow in and out of the lungs.
4. Complete airway obstruction: This occurs when the airway is completely blocked, preventing any air from flowing into or out of the lungs.

Treatment for airway obstruction depends on the underlying cause of the condition. In some cases, removing the obstruction may be as simple as clearing the airway of foreign objects or mucus. In other cases, more invasive treatments such as surgery may be necessary.

Bronchial provocation tests are a group of medical tests used to assess the airway responsiveness of the lungs by challenging them with increasing doses of a specific stimulus, such as methacholine or histamine, which can cause bronchoconstriction (narrowing of the airways) in susceptible individuals. These tests are often performed to diagnose and monitor asthma and other respiratory conditions that may be associated with heightened airway responsiveness.

The most common type of bronchial provocation test is the methacholine challenge test, which involves inhaling increasing concentrations of methacholine aerosol via a nebulizer. The dose response is measured by monitoring lung function (usually through spirometry) before and after each exposure. A positive test is indicated when there is a significant decrease in forced expiratory volume in one second (FEV1) or other measures of airflow, which suggests bronchial hyperresponsiveness.

Other types of bronchial provocation tests include histamine challenges, exercise challenges, and mannitol challenges. These tests have specific indications, contraindications, and protocols that should be followed to ensure accurate results and patient safety. Bronchial provocation tests are typically conducted in a controlled clinical setting under the supervision of trained healthcare professionals.

Adrenergic beta-2 receptor agonists are a class of medications that bind to and stimulate beta-2 adrenergic receptors, which are found in various tissues throughout the body, including the lungs, blood vessels, and skeletal muscles. These receptors are part of the sympathetic nervous system and play a role in regulating various physiological processes such as heart rate, blood pressure, and airway diameter.

When beta-2 receptor agonists bind to these receptors, they cause bronchodilation (opening of the airways), relaxation of smooth muscle, and increased heart rate and force of contraction. These effects make them useful in the treatment of conditions such as asthma, chronic obstructive pulmonary disease (COPD), and premature labor.

Examples of adrenergic beta-2 receptor agonists include albuterol, terbutaline, salmeterol, and formoterol. These medications can be administered by inhalation, oral administration, or injection, depending on the specific drug and the condition being treated.

It's important to note that while adrenergic beta-2 receptor agonists are generally safe and effective when used as directed, they can have side effects such as tremors, anxiety, palpitations, and headaches. In addition, long-term use of some beta-2 agonists has been associated with increased risk of severe asthma exacerbations and even death in some cases. Therefore, it's important to use these medications only as directed by a healthcare provider and to report any concerning symptoms promptly.

An inhalation spacer is a medical device used in conjunction with metered-dose inhalers (MDIs) to improve the delivery and effectiveness of respiratory medications. It creates a space or chamber between the MDI and the patient's airways, allowing the medication to be more evenly distributed in a fine mist. This helps reduce the amount of medication that may otherwise be deposited in the back of the throat or lost in the air, ensuring that more of it reaches the intended target in the lungs. Inhalation spacers are particularly useful for children and older adults who may have difficulty coordinating their breathing with the activation of the MDI.

Clemastine is an antihistamine medication that is used to relieve symptoms of allergies, such as runny nose, sneezing, and itchy or watery eyes. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Clemastine is available in oral tablet and liquid forms, and is typically taken twice daily with a full glass of water.

Common side effects of clemastine include drowsiness, dry mouth, headache, and upset stomach. It is important to avoid activities that require mental alertness, such as driving or operating heavy machinery, until you know how the medication affects you. Clemastine may also cause dizziness, so it is best to avoid getting up too quickly from a sitting or lying position.

Like all medications, clemastine should be taken only as directed by your healthcare provider. It is important to inform them of any other medications you are taking, as well as any medical conditions you may have, as clemastine can interact with certain drugs and may not be suitable for everyone.

Methacholine chloride is a medication that is used as a diagnostic tool to help identify and assess the severity of asthma or other respiratory conditions that cause airway hyperresponsiveness. It is a synthetic derivative of acetylcholine, which is a neurotransmitter that causes smooth muscle contraction in the body.

When methacholine chloride is inhaled, it stimulates the muscarinic receptors in the airways, causing them to constrict or narrow. This response is measured and used to determine the degree of airway hyperresponsiveness, which can help diagnose asthma and assess its severity.

The methacholine challenge test involves inhaling progressively higher doses of methacholine chloride until a significant decrease in lung function is observed or until a maximum dose is reached. The test results are then used to guide treatment decisions and monitor the effectiveness of therapy. It's important to note that this test should be conducted under the supervision of a healthcare professional, as it carries some risks, including bronchoconstriction and respiratory distress.

The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.

"Bronchi" are a pair of airways in the respiratory system that branch off from the trachea (windpipe) and lead to the lungs. They are responsible for delivering oxygen-rich air to the lungs and removing carbon dioxide during exhalation. The right bronchus is slightly larger and more vertical than the left, and they further divide into smaller branches called bronchioles within the lungs. Any abnormalities or diseases affecting the bronchi can impact lung function and overall respiratory health.

Chlorofluorocarbons (CFCs) are synthetic, volatile organic compounds that consist of carbon atoms, chlorine atoms, and fluorine atoms. They were widely used in various applications such as refrigerants, aerosol propellants, solvents, and fire extinguishing agents due to their non-toxicity, non-flammability, and chemical stability.

However, CFCs have been found to contribute significantly to the depletion of the Earth's ozone layer when released into the atmosphere. This is because they are stable enough to reach the upper atmosphere, where they react with ultraviolet radiation to release chlorine atoms that can destroy ozone molecules. As a result, the production and use of CFCs have been phased out under the Montreal Protocol, an international treaty aimed at protecting the ozone layer.

Respiratory therapy is a healthcare profession that specializes in the diagnosis, treatment, and management of respiratory disorders and diseases. Respiratory therapists (RTs) work under the direction of physicians to provide care for patients with conditions such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, sleep apnea, and neuromuscular diseases that affect breathing.

RTs use a variety of techniques and treatments to help patients breathe more easily, including oxygen therapy, aerosol medication delivery, chest physiotherapy, mechanical ventilation, and patient education. They also perform diagnostic tests such as pulmonary function studies to assess lung function and help diagnose respiratory conditions.

RTs work in a variety of healthcare settings, including hospitals, clinics, long-term care facilities, and home health agencies. They may provide care for patients of all ages, from premature infants to the elderly. The overall goal of respiratory therapy is to help patients achieve and maintain optimal lung function and quality of life.

Ethanolamines are a class of organic compounds that contain an amino group (-NH2) and a hydroxyl group (-OH) attached to a carbon atom. They are derivatives of ammonia (NH3) in which one or two hydrogen atoms have been replaced by a ethanol group (-CH2CH2OH).

The most common ethanolamines are:

* Monethanolamine (MEA), also called 2-aminoethanol, with the formula HOCH2CH2NH2.
* Diethanolamine (DEA), also called 2,2'-iminobisethanol, with the formula HOCH2CH2NHCH2CH2OH.
* Triethanolamine (TEA), also called 2,2',2''-nitrilotrisethanol, with the formula N(CH2CH2OH)3.

Ethanolamines are used in a wide range of industrial and consumer products, including as solvents, emulsifiers, detergents, pharmaceuticals, and personal care products. They also have applications as intermediates in the synthesis of other chemicals. In the body, ethanolamines play important roles in various biological processes, such as neurotransmission and cell signaling.

Inspiratory Capacity (IC) is the maximum volume of air that can be breathed in after a normal expiration. It is the sum of the tidal volume (the amount of air displaced between normal inspiration and expiration during quiet breathing) and the inspiratory reserve volume (the additional amount of air that can be inspired over and above the tidal volume). IC is an important parameter used in pulmonary function testing to assess lung volumes and capacities in patients with respiratory disorders.

The Respiratory Therapy Department in a hospital is a specialized area that provides diagnostic and therapeutic services to patients with respiratory disorders or conditions that affect their breathing. The department is typically staffed by licensed respiratory therapists who work under the direction of pulmonologists or other medical professionals.

Respiratory therapists use various techniques and equipment to assess, treat, and manage patients' respiratory needs. This may include administering oxygen therapy, aerosol treatments, chest physiotherapy, mechanical ventilation, and other life support measures. They also provide education and counseling to patients and their families on topics such as breathing exercises, medication management, and lifestyle modifications to improve respiratory health.

The Respiratory Therapy Department may be responsible for providing services in various hospital settings, including intensive care units, emergency departments, operating rooms, and pulmonary function labs. They work closely with other healthcare professionals, such as physicians, nurses, and respiratory technologists, to provide comprehensive care to patients with respiratory conditions.

Maximal Expiratory Flow Rate (MEFR) is a measure of how quickly a person can exhale air from their lungs. It is often used in pulmonary function testing to assess the degree of airflow obstruction in conditions such as chronic obstructive pulmonary disease (COPD) or asthma.

The MEFR is typically measured by having the person take a deep breath and then exhale as forcefully and quickly as possible into a device that measures the volume and flow of air. The MEFR is calculated as the maximum flow rate achieved during the exhalation maneuver, usually expressed in liters per second (L/s) or seconds (L/sec).

MEFR can be measured at different lung volumes, such as at functional residual capacity (FRC) or at total lung capacity (TLC), to provide additional information about the severity and location of airflow obstruction. However, MEFR is not as commonly used in clinical practice as other measures of pulmonary function, such as forced expiratory volume in one second (FEV1) or forced vital capacity (FVC).

Antitussive agents are medications that are used to suppress cough. They work by numbing the throat and interrupting the cough reflex. Some common antitussives include dextromethorphan, codeine, and hydrocodone. These medications can be found in various over-the-counter and prescription cough and cold products. It is important to use antitussives only as directed, as they can have side effects such as drowsiness, constipation, and slowed breathing. Additionally, it's important to note that long term use of opioid antitussive like codeine and hydrocodone are not recommended due to the risk of addiction and other serious side effects.

Cholinergic antagonists, also known as anticholinergics or parasympatholytics, are a class of drugs that block the action of the neurotransmitter acetylcholine in the nervous system. They achieve this by binding to and blocking the activation of muscarinic acetylcholine receptors, which are found in various organs throughout the body, including the eyes, lungs, heart, gastrointestinal tract, and urinary bladder.

The blockade of these receptors results in a range of effects depending on the specific organ system involved. For example, cholinergic antagonists can cause mydriasis (dilation of the pupils), cycloplegia (paralysis of the ciliary muscle of the eye), tachycardia (rapid heart rate), reduced gastrointestinal motility and secretion, urinary retention, and respiratory tract smooth muscle relaxation.

Cholinergic antagonists are used in a variety of clinical settings, including the treatment of conditions such as Parkinson's disease, chronic obstructive pulmonary disease (COPD), asthma, gastrointestinal disorders, and urinary incontinence. Some common examples of cholinergic antagonists include atropine, scopolamine, ipratropium, and oxybutynin.

It's important to note that cholinergic antagonists can have significant side effects, particularly when used in high doses or in combination with other medications that affect the nervous system. These side effects can include confusion, memory impairment, hallucinations, delirium, and blurred vision. Therefore, it's essential to use these drugs under the close supervision of a healthcare provider and to follow their instructions carefully.

Bronchial spasm refers to a sudden constriction or tightening of the muscles in the bronchial tubes, which are the airways that lead to the lungs. This constriction can cause symptoms such as coughing, wheezing, and difficulty breathing. Bronchial spasm is often associated with respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. In these conditions, the airways are sensitive to various triggers such as allergens, irritants, or infections, which can cause the muscles in the airways to contract and narrow. This can make it difficult for air to flow in and out of the lungs, leading to symptoms such as shortness of breath, wheezing, and coughing. Bronchial spasm can be treated with medications that help to relax the muscles in the airways and open up the airways, such as bronchodilators and anti-inflammatory drugs.

Theophylline is a medication that belongs to a class of drugs called methylxanthines. It is used in the management of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and other conditions that cause narrowing of the airways in the lungs.

Theophylline works by relaxing the smooth muscle around the airways, which helps to open them up and make breathing easier. It also acts as a bronchodilator, increasing the flow of air into and out of the lungs. Additionally, theophylline has anti-inflammatory effects that can help reduce swelling in the airways and relieve symptoms such as coughing, wheezing, and shortness of breath.

Theophylline is available in various forms, including tablets, capsules, and liquid solutions. It is important to take this medication exactly as prescribed by a healthcare provider, as the dosage may vary depending on individual factors such as age, weight, and liver function. Regular monitoring of blood levels of theophylline is also necessary to ensure safe and effective use of the medication.

Nedocromil is not a medication that has direct therapeutic use, but it is the active ingredient in a prescription eye drop and inhaler medication called "nedocromil sodium." Therefore, I will provide you with the definition of nedocromil sodium.

Nedocromil sodium is a medication used to prevent asthma symptoms and allergic rhinitis (hay fever) symptoms. It belongs to a class of medications called mast cell stabilizers, which work by preventing the release of chemicals from certain cells in the body that cause inflammation and allergic reactions.

Nedocromil sodium is available as an eye drop solution for the prevention of itching associated with allergic conjunctivitis and as a metered-dose inhaler for the prevention of asthma symptoms. It is typically used on a regular basis to help prevent symptoms from occurring, rather than to treat acute symptoms.

It's important to note that nedocromil sodium is not a bronchodilator or a steroid medication and should not be used as a replacement for these types of medications if they have been prescribed by your healthcare provider.

"Indans" is not a recognized medical term or abbreviation in the field of medicine or pharmacology. It's possible that you may be referring to "indanes," which are chemical compounds that contain a indane ring structure, consisting of two benzene rings fused in an angular arrangement. Some indane derivatives have been studied for their potential medicinal properties, such as anti-inflammatory and analgesic effects. However, it's important to note that the medical use and efficacy of these compounds can vary widely and should be evaluated on a case-by-case basis under the guidance of a qualified healthcare professional.

Anti-asthmatic agents are a class of medications used to prevent or alleviate the symptoms of asthma, such as wheezing, shortness of breath, and coughing. These medications work by reducing inflammation, relaxing muscles in the airways, and preventing allergic reactions that can trigger an asthma attack.

There are several types of anti-asthmatic agents, including:

1. Bronchodilators: These medications relax the muscles around the airways, making it easier to breathe. They can be short-acting or long-acting, depending on how long they work.
2. Inhaled corticosteroids: These medications reduce inflammation in the airways and help prevent asthma symptoms from occurring.
3. Leukotriene modifiers: These medications block the action of leukotrienes, chemicals that contribute to inflammation and narrowing of the airways.
4. Combination therapies: Some anti-asthmatic agents combine different types of medications, such as a bronchodilator and an inhaled corticosteroid, into one inhaler.
5. Biologics: These are newer types of anti-asthmatic agents that target specific molecules involved in the inflammatory response in asthma. They are usually given by injection.

It's important to note that different people with asthma may require different medications or combinations of medications to manage their symptoms effectively. Therefore, it is essential to work closely with a healthcare provider to determine the best treatment plan for each individual.

Bronchoconstrictor agents are substances that cause narrowing or constriction of the bronchioles, the small airways in the lungs. This can lead to symptoms such as wheezing, coughing, and shortness of breath. Bronchoconstrictor agents include certain medications (such as some beta-blockers and prostaglandin F2alpha), environmental pollutants (such as tobacco smoke and air pollution particles), and allergens (such as dust mites and pollen).

In contrast to bronchodilator agents, which are medications that widen the airways and improve breathing, bronchoconstrictor agents can make it more difficult for a person to breathe. People with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD) may be particularly sensitive to bronchoconstrictor agents and may experience severe symptoms when exposed to them.

A cross-over study is a type of experimental design in which participants receive two or more interventions in a specific order. After a washout period, each participant receives the opposite intervention(s). The primary advantage of this design is that it controls for individual variability by allowing each participant to act as their own control.

In medical research, cross-over studies are often used to compare the efficacy or safety of two treatments. For example, a researcher might conduct a cross-over study to compare the effectiveness of two different medications for treating high blood pressure. Half of the participants would be randomly assigned to receive one medication first and then switch to the other medication after a washout period. The other half of the participants would receive the opposite order of treatments.

Cross-over studies can provide valuable insights into the relative merits of different interventions, but they also have some limitations. For example, they may not be suitable for studying conditions that are chronic or irreversible, as it may not be possible to completely reverse the effects of the first intervention before administering the second one. Additionally, carryover effects from the first intervention can confound the results if they persist into the second treatment period.

Overall, cross-over studies are a useful tool in medical research when used appropriately and with careful consideration of their limitations.

Forced expiratory flow rates (FEFR) are measures of how quickly and efficiently air can be exhaled from the lungs during a forced breath maneuver. These measurements are often used in pulmonary function testing to help diagnose and monitor obstructive lung diseases such as asthma or chronic obstructive pulmonary disease (COPD).

FEFR is typically measured during a forced expiratory maneuver, where the person takes a deep breath in and then exhales as forcefully and quickly as possible into a mouthpiece connected to a spirometer. The spirometer measures the volume and flow rate of the exhaled air over time.

There are several different FEFR measurements that can be reported, including:

* Forced Expiratory Flow (FEF) 25-75%: This is the average flow rate during the middle half of the forced expiratory maneuver.
* Peak Expiratory Flow Rate (PEFR): This is the maximum flow rate achieved during the first second of the forced expiratory maneuver.
* Forced Expiratory Volume in 1 Second (FEV1): This is the volume of air exhaled in the first second of the forced expiratory maneuver.

Abnormal FEFR values can indicate obstruction in the small airways of the lungs, which can make it difficult to breathe out fully and quickly. The specific pattern of abnormalities in FEFR measurements can help doctors differentiate between different types of obstructive lung diseases.

Amino alcohols are organic compounds containing both amine and hydroxyl (alcohol) functional groups. They have the general structure R-NH-OH, where R represents a carbon-containing group. Amino alcohols can be primary, secondary, or tertiary, depending on the number of alkyl or aryl groups attached to the nitrogen atom.

These compounds are important in many chemical and biological processes. For example, some amino alcohols serve as intermediates in the synthesis of pharmaceuticals, dyes, and polymers. In biochemistry, certain amino alcohols function as neurotransmitters or components of lipids.

Some common examples of amino alcohols include:

* Ethanolamine (monoethanolamine, MEA): a primary amino alcohol used in the production of detergents, emulsifiers, and pharmaceuticals
* Serinol: a primary amino alcohol that occurs naturally in some foods and is used as a flavoring agent
* Choline: a quaternary ammonium compound with a hydroxyl group, essential for human nutrition and found in various foods such as eggs, liver, and peanuts
* Trimethylamine (TMA): a tertiary amino alcohol that occurs naturally in some marine animals and is responsible for the "fishy" odor of their flesh.

A cough is a reflex action that helps to clear the airways of irritants, foreign particles, or excess mucus or phlegm. It is characterized by a sudden, forceful expulsion of air from the lungs through the mouth and nose. A cough can be acute (short-term) or chronic (long-term), and it can be accompanied by other symptoms such as chest pain, shortness of breath, or fever. Coughing can be caused by various factors, including respiratory infections, allergies, asthma, environmental pollutants, gastroesophageal reflux disease (GERD), and chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and bronchitis. In some cases, a cough may be a symptom of a more serious underlying condition, such as heart failure or lung cancer.

Aminophylline is a medication that is used to treat and prevent respiratory symptoms such as bronchospasm, wheezing, and shortness of breath. It is a combination of theophylline and ethylenediamine, and it works by relaxing muscles in the airways and increasing the efficiency of the diaphragm, which makes breathing easier.

Aminophylline is classified as a xanthine derivative and a methylxanthine bronchodilator. It is available in various forms, including tablets, capsules, and liquid solutions, and it is typically taken by mouth two to three times a day. The medication may also be given intravenously in hospital settings for the treatment of acute respiratory distress.

Common side effects of aminophylline include nausea, vomiting, headache, and insomnia. More serious side effects can occur at higher doses and may include irregular heartbeat, seizures, and potentially life-threatening allergic reactions. It is important to follow the dosage instructions carefully and to monitor for any signs of adverse reactions while taking this medication.

Functional Residual Capacity (FRC) is the volume of air that remains in the lungs after normal expiration during quiet breathing. It represents the sum of the residual volume (RV) and the expiratory reserve volume (ERV). The FRC is approximately 2.5-3.5 liters in a healthy adult. This volume of air serves to keep the alveoli open and maintain oxygenation during periods of quiet breathing, as well as providing a reservoir for additional ventilation during increased activity or exercise.

Glycopyrrolate is an anticholinergic medication that works by blocking the action of acetylcholine, a chemical messenger in the body. It reduces the secretions of certain organs and is used to treat various conditions such as peptic ulcers, reducing saliva production during surgical procedures, preventing motion sickness, and managing some symptoms of Parkinson's disease.

In medical terms, glycopyrrolate is a competitive antagonist of muscarinic acetylcholine receptors. It has a particular affinity for the M1, M2, and M3 receptor subtypes. By blocking these receptors, it inhibits the parasympathetic nervous system's effects on various organs, leading to decreased glandular secretions (such as saliva, sweat, and gastric acid), slowed heart rate, and relaxation of smooth muscles in the digestive tract and bronchioles.

Glycopyrrolate is available in oral, intravenous, and topical forms and should be used under the supervision of a healthcare professional due to its potential side effects, including dry mouth, blurred vision, dizziness, drowsiness, and urinary retention.

A lung is a pair of spongy, elastic organs in the chest that work together to enable breathing. They are responsible for taking in oxygen and expelling carbon dioxide through the process of respiration. The left lung has two lobes, while the right lung has three lobes. The lungs are protected by the ribcage and are covered by a double-layered membrane called the pleura. The trachea divides into two bronchi, which further divide into smaller bronchioles, leading to millions of tiny air sacs called alveoli, where the exchange of gases occurs.

The adrenal cortex hormones are a group of steroid hormones produced and released by the outer portion (cortex) of the adrenal glands, which are located on top of each kidney. These hormones play crucial roles in regulating various physiological processes, including:

1. Glucose metabolism: Cortisol helps control blood sugar levels by increasing glucose production in the liver and reducing its uptake in peripheral tissues.
2. Protein and fat metabolism: Cortisol promotes protein breakdown and fatty acid mobilization, providing essential building blocks for energy production during stressful situations.
3. Immune response regulation: Cortisol suppresses immune function to prevent overactivation and potential damage to the body during stress.
4. Cardiovascular function: Aldosterone regulates electrolyte balance and blood pressure by promoting sodium reabsorption and potassium excretion in the kidneys.
5. Sex hormone production: The adrenal cortex produces small amounts of sex hormones, such as androgens and estrogens, which contribute to sexual development and function.
6. Growth and development: Cortisol plays a role in normal growth and development by influencing the activity of growth-promoting hormones like insulin-like growth factor 1 (IGF-1).

The main adrenal cortex hormones include:

1. Glucocorticoids: Cortisol is the primary glucocorticoid, responsible for regulating metabolism and stress response.
2. Mineralocorticoids: Aldosterone is the primary mineralocorticoid, involved in electrolyte balance and blood pressure regulation.
3. Androgens: Dehydroepiandrosterone (DHEA) and its sulfate derivative (DHEAS) are the most abundant adrenal androgens, contributing to sexual development and function.
4. Estrogens: Small amounts of estrogens are produced by the adrenal cortex, mainly in women.

Disorders related to impaired adrenal cortex hormone production or regulation can lead to various clinical manifestations, such as Addison's disease (adrenal insufficiency), Cushing's syndrome (hypercortisolism), and congenital adrenal hyperplasia (CAH).

Respiratory sounds are the noises produced by the airflow through the respiratory tract during breathing. These sounds can provide valuable information about the health and function of the lungs and airways. They are typically categorized into two main types: normal breath sounds and adventitious (or abnormal) breath sounds.

Normal breath sounds include:

1. Vesicular breath sounds: These are soft, low-pitched sounds heard over most of the lung fields during quiet breathing. They are produced by the movement of air through the alveoli and smaller bronchioles.
2. Bronchovesicular breath sounds: These are medium-pitched, hollow sounds heard over the mainstem bronchi and near the upper sternal border during both inspiration and expiration. They are a combination of vesicular and bronchial breath sounds.

Abnormal or adventitious breath sounds include:

1. Crackles (or rales): These are discontinuous, non-musical sounds that resemble the crackling of paper or bubbling in a fluid-filled container. They can be heard during inspiration and are caused by the sudden opening of collapsed airways or the movement of fluid within the airways.
2. Wheezes: These are continuous, musical sounds resembling a whistle. They are produced by the narrowing or obstruction of the airways, causing turbulent airflow.
3. Rhonchi: These are low-pitched, rumbling, continuous sounds that can be heard during both inspiration and expiration. They are caused by the vibration of secretions or fluids in the larger airways.
4. Stridor: This is a high-pitched, inspiratory sound that resembles a harsh crowing or barking noise. It is usually indicative of upper airway narrowing or obstruction.

The character, location, and duration of respiratory sounds can help healthcare professionals diagnose various respiratory conditions, such as pneumonia, chronic obstructive pulmonary disease (COPD), asthma, and bronchitis.

Beclomethasone is a corticosteroid medication that is used to treat inflammation and allergies in the body. It works by reducing the activity of the immune system, which helps to prevent the release of substances that cause inflammation. Beclomethasone is available as an inhaler, nasal spray, and cream or ointment.

In its inhaled form, beclomethasone is used to treat asthma and other lung conditions such as chronic obstructive pulmonary disease (COPD). It helps to prevent symptoms such as wheezing and shortness of breath by reducing inflammation in the airways.

As a nasal spray, beclomethasone is used to treat allergies and inflammation in the nose, such as hay fever or rhinitis. It can help to relieve symptoms such as sneezing, runny or stuffy nose, and itching.

Beclomethasone cream or ointment is used to treat skin conditions such as eczema, dermatitis, and psoriasis. It works by reducing inflammation in the skin and relieving symptoms such as redness, swelling, itching, and irritation.

It's important to note that beclomethasone can have side effects, especially if used in high doses or for long periods of time. These may include thrush (a fungal infection in the mouth), coughing, hoarseness, sore throat, and easy bruising or thinning of the skin. It's important to follow your healthcare provider's instructions carefully when using beclomethasone to minimize the risk of side effects.

Respiratory Care Units (RCUs) are specialized departments within hospitals that provide comprehensive care to patients with respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, lung cancer, and sleep-disordered breathing. These units are staffed with specially trained healthcare professionals, including respiratory therapists, pulmonologists, nurses, and other specialists who work together to diagnose, treat, and manage patients' respiratory conditions.

RCUs may provide a range of services, including:

1. Diagnostic testing: This includes pulmonary function tests, arterial blood gas analysis, chest X-rays, CT scans, and other diagnostic procedures to assess the patient's lung function and identify any underlying respiratory conditions.
2. Medication management: RCUs may provide a variety of medications to help manage patients' respiratory symptoms, such as bronchodilators, corticosteroids, and antibiotics.
3. Oxygen therapy: Patients in RCUs may require oxygen therapy to help them breathe more easily. This can be delivered through various devices, including nasal cannulas, face masks, or oxygen hoods.
4. Mechanical ventilation: In severe cases of respiratory failure, patients may require mechanical ventilation to support their breathing. RCUs are equipped with advanced ventilators and other respiratory equipment to provide this care.
5. Pulmonary rehabilitation: RCUs may offer pulmonary rehabilitation programs to help patients manage their respiratory conditions and improve their overall quality of life. These programs may include exercise training, education, and counseling.
6. Sleep disorders management: Some RCUs may also provide care for patients with sleep-disordered breathing, such as obstructive sleep apnea. This can include diagnostic testing, continuous positive airway pressure (CPAP) therapy, and other treatments.

Overall, Respiratory Care Units play a critical role in the diagnosis, treatment, and management of respiratory disorders, helping patients to breathe more easily and improve their quality of life.

Butylamines are a class of organic compounds that contain a butyl group (a chain of four carbon atoms) attached to an amine functional group, which consists of nitrogen atom bonded to one or more hydrogen atoms. The general structure of a primary butylamine is R-NH2, where R represents the butyl group.

Butylamines can be found in various natural and synthetic substances. Some of them have important uses in industry as solvents, intermediates in chemical synthesis, or building blocks for pharmaceuticals. However, some butylamines are also known to have psychoactive effects and may be used as recreational drugs or abused.

It is worth noting that the term "butylamine" can refer to any of several specific compounds, depending on the context. For example, n-butylamine (also called butan-1-amine) has the formula CH3CH2CH2CH2NH2, while tert-butylamine (also called 2-methylpropan-2-amine) has the formula (CH3)3CNH2. These two compounds have different physical and chemical properties due to their structural differences.

In a medical context, butylamines may be encountered as drugs of abuse or as components of pharmaceuticals. Some examples of butylamine-derived drugs include certain antidepressants, anesthetics, and muscle relaxants. However, it is important to note that these compounds are often highly modified from their parent butylamine structure, and may not resemble them closely in terms of their pharmacological properties or toxicity profiles.

Budesonide is a corticosteroid medication that is used to reduce inflammation in the body. It works by mimicking the effects of hormones produced naturally by the adrenal glands, which help regulate the immune system and suppress inflammatory responses. Budesonide is available as an inhaler, nasal spray, or oral tablet, and is used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), rhinitis, and Crohn's disease.

When budesonide is inhaled or taken orally, it is absorbed into the bloodstream and travels throughout the body, where it can reduce inflammation in various tissues and organs. In the lungs, for example, budesonide can help prevent asthma attacks by reducing inflammation in the airways, making it easier to breathe.

Like other corticosteroid medications, budesonide can have side effects, particularly if used at high doses or for long periods of time. These may include thrush (a fungal infection in the mouth), hoarseness, sore throat, cough, headache, and easy bruising or skin thinning. Long-term use of corticosteroids can also lead to more serious side effects, such as adrenal suppression, osteoporosis, and increased risk of infections.

It is important to follow the dosage instructions provided by your healthcare provider when taking budesonide or any other medication, and to report any unusual symptoms or side effects promptly.

Parasympatholytics are a type of medication that blocks the action of the parasympathetic nervous system. The parasympathetic nervous system is responsible for the body's rest and digest response, which includes slowing the heart rate, increasing intestinal and glandular activity, and promoting urination and defecation.

Parasympatholytics work by selectively binding to muscarinic receptors, which are found in various organs throughout the body, including the heart, lungs, and digestive system. By blocking these receptors, parasympatholytics can cause a range of effects, such as an increased heart rate, decreased glandular secretions, and reduced intestinal motility.

Some common examples of parasympatholytics include atropine, scopolamine, and ipratropium. These medications are often used to treat conditions such as bradycardia (slow heart rate), excessive salivation, and gastrointestinal cramping or diarrhea. However, because they can have significant side effects, parasympatholytics are typically used only when necessary and under the close supervision of a healthcare provider.

The trachea, also known as the windpipe, is a tube-like structure in the respiratory system that connects the larynx (voice box) to the bronchi (the two branches leading to each lung). It is composed of several incomplete rings of cartilage and smooth muscle, which provide support and flexibility. The trachea plays a crucial role in directing incoming air to the lungs during inspiration and outgoing air to the larynx during expiration.

Nasal decongestants are medications that are used to relieve nasal congestion, or a "stuffy nose," by narrowing the blood vessels in the lining of the nose, which helps to reduce swelling and inflammation. This can help to make breathing easier and can also help to alleviate other symptoms associated with nasal congestion, such as sinus pressure and headache.

There are several different types of nasal decongestants available, including over-the-counter (OTC) and prescription options. Some common OTC nasal decongestants include pseudoephedrine (Sudafed) and phenylephrine (Neo-Synephrine), which are available in the form of tablets, capsules, liquids, and nasal sprays. Prescription nasal decongestants may be stronger than OTC options and may be prescribed for longer periods of time.

It is important to follow the instructions on the label when using nasal decongestants, as they can have side effects if not used properly. Some potential side effects of nasal decongestants include increased heart rate, blood pressure, and anxiety. It is also important to note that nasal decongestants should not be used for longer than a few days at a time, as prolonged use can actually make nasal congestion worse (this is known as "rebound congestion"). If you have any questions about using nasal decongestants or if your symptoms persist, it is best to speak with a healthcare provider.

Bronchitis is a medical condition characterized by inflammation of the bronchi, which are the large airways that lead to the lungs. This inflammation can cause a variety of symptoms, including coughing, wheezing, chest tightness, and shortness of breath. Bronchitis can be either acute or chronic.

Acute bronchitis is usually caused by a viral infection, such as a cold or the flu, and typically lasts for a few days to a week. Symptoms may include a productive cough (coughing up mucus or phlegm), chest discomfort, and fatigue. Acute bronchitis often resolves on its own without specific medical treatment, although rest, hydration, and over-the-counter medications to manage symptoms may be helpful.

Chronic bronchitis, on the other hand, is a long-term condition that is characterized by a persistent cough with mucus production that lasts for at least three months out of the year for two consecutive years. Chronic bronchitis is typically caused by exposure to irritants such as cigarette smoke, air pollution, or occupational dusts and chemicals. It is often associated with chronic obstructive pulmonary disease (COPD), which includes both chronic bronchitis and emphysema.

Treatment for chronic bronchitis may include medications to help open the airways, such as bronchodilators and corticosteroids, as well as lifestyle changes such as smoking cessation and avoiding irritants. In severe cases, oxygen therapy or lung transplantation may be necessary.

Aerosol propellants are substances used to expel aerosolized particles from a container. They are typically gases that are stored under pressure in a container and, when the container is opened or activated, the gas expands and forces the contents out through a small opening. The most commonly used aerosol propellants are hydrocarbons such as butane and propane, although fluorinated hydrocarbons such as difluoroethane and tetrafluoroethane are also used. Aerosol propellants can be found in various products including medical inhalers, cosmetics, and food products. It is important to handle aerosol propellants with care, as they can be flammable or harmful if inhaled or ingested.

Oscillometry is a non-invasive method to measure various mechanical properties of the respiratory system, including lung volumes and airway resistance. It involves applying small pressure oscillations to the airways and measuring the resulting flow or volume changes. The technique can be used to assess lung function in patients with obstructive or restrictive lung diseases, as well as in healthy individuals. Oscillometry is often performed during tidal breathing, making it a comfortable method for both children and adults who may have difficulty performing traditional spirometry maneuvers.

Pulmonary ventilation, also known as pulmonary respiration or simply ventilation, is the process of moving air into and out of the lungs to facilitate gas exchange. It involves two main phases: inhalation (or inspiration) and exhalation (or expiration). During inhalation, the diaphragm and external intercostal muscles contract, causing the chest volume to increase and the pressure inside the chest to decrease, which then draws air into the lungs. Conversely, during exhalation, these muscles relax, causing the chest volume to decrease and the pressure inside the chest to increase, which pushes air out of the lungs. This process ensures that oxygen-rich air from the atmosphere enters the alveoli (air sacs in the lungs), where it can diffuse into the bloodstream, while carbon dioxide-rich air from the bloodstream in the capillaries surrounding the alveoli is expelled out of the body.

Residual Volume (RV) is the amount of air that remains in the lungs after a forced exhale, also known as the "expiratory reserve volume." It is the lowest lung volume that can be reached during a forced exhalation and cannot be completely emptied due to the presence of alveoli that are too small or too far from the airways. This volume is important for maintaining the structural integrity of the lungs and preventing their collapse. Any additional air that enters the lungs after this point will increase the total lung capacity. The normal residual volume for an average adult human is typically around 1 to 1.5 liters.

Dyspnea is defined as difficulty or discomfort in breathing, often described as shortness of breath. It can range from mild to severe, and may occur during rest, exercise, or at any time. Dyspnea can be caused by various medical conditions, including heart and lung diseases, anemia, and neuromuscular disorders. It is important to seek medical attention if experiencing dyspnea, as it can be a sign of a serious underlying condition.

Tephrosia is a genus of flowering plants in the pea family, Fabaceae. It includes several species that are native to tropical and subtropical regions around the world. Some common names for Tephrosia include wild sensitive plant, fish poison pea, and devil's shrub.

In a medical context, Tephrosia is not widely recognized or used as a treatment. However, some species of Tephrosia have been reported to have medicinal properties in traditional medicine. For example, Tephrosia purpurea has been used in Ayurvedic medicine to treat a variety of conditions, including skin diseases, inflammation, and fever. The roots and leaves of this plant contain various chemical compounds that may have therapeutic effects, such as tannins, saponins, and alkaloids.

It is important to note that the use of Tephrosia or any other herbal remedy should be done under the guidance of a qualified healthcare provider, as these substances can interact with other medications and have potential side effects. Additionally, more research is needed to confirm the safety and efficacy of Tephrosia for medical purposes.

Quinolones are a class of antibacterial agents that are widely used in medicine to treat various types of infections caused by susceptible bacteria. These synthetic drugs contain a chemical structure related to quinoline and have broad-spectrum activity against both Gram-positive and Gram-negative bacteria. Quinolones work by inhibiting the bacterial DNA gyrase or topoisomerase IV enzymes, which are essential for bacterial DNA replication, transcription, and repair.

The first quinolone antibiotic was nalidixic acid, discovered in 1962. Since then, several generations of quinolones have been developed, with each generation having improved antibacterial activity and a broader spectrum of action compared to the previous one. The various generations of quinolones include:

1. First-generation quinolones (e.g., nalidixic acid): Primarily used for treating urinary tract infections caused by Gram-negative bacteria.
2. Second-generation quinolones (e.g., ciprofloxacin, ofloxacin, norfloxacin): These drugs have improved activity against both Gram-positive and Gram-negative bacteria and are used to treat a wider range of infections, including respiratory, gastrointestinal, and skin infections.
3. Third-generation quinolones (e.g., levofloxacin, sparfloxacin, grepafloxacin): These drugs have enhanced activity against Gram-positive bacteria, including some anaerobes and atypical organisms like Legionella and Mycoplasma species.
4. Fourth-generation quinolones (e.g., moxifloxacin, gatifloxacin): These drugs have the broadest spectrum of activity, including enhanced activity against Gram-positive bacteria, anaerobes, and some methicillin-resistant Staphylococcus aureus (MRSA) strains.

Quinolones are generally well-tolerated, but like all medications, they can have side effects. Common adverse reactions include gastrointestinal symptoms (nausea, vomiting, diarrhea), headache, and dizziness. Serious side effects, such as tendinitis, tendon rupture, peripheral neuropathy, and QT interval prolongation, are less common but can occur, particularly in older patients or those with underlying medical conditions. The use of quinolones should be avoided or used cautiously in these populations.

Quinolone resistance has become an increasing concern due to the widespread use of these antibiotics. Bacteria can develop resistance through various mechanisms, including chromosomal mutations and the acquisition of plasmid-mediated quinolone resistance genes. The overuse and misuse of quinolones contribute to the emergence and spread of resistant strains, which can limit treatment options for severe infections caused by these bacteria. Therefore, it is essential to use quinolones judiciously and only when clinically indicated, to help preserve their effectiveness and prevent further resistance development.

Total Lung Capacity (TLC) is the maximum volume of air that can be contained within the lungs at the end of a maximal inspiration. It includes all of the following lung volumes: tidal volume, inspiratory reserve volume, expiratory reserve volume, and residual volume. TLC can be measured directly using gas dilution techniques or indirectly by adding residual volume to vital capacity. Factors that affect TLC include age, sex, height, and lung health status.

Muscarinic antagonists, also known as muscarinic receptor antagonists or parasympatholytics, are a class of drugs that block the action of acetylcholine at muscarinic receptors. Acetylcholine is a neurotransmitter that plays an important role in the parasympathetic nervous system, which helps to regulate various bodily functions such as heart rate, digestion, and respiration.

Muscarinic antagonists work by binding to muscarinic receptors, which are found in various organs throughout the body, including the eyes, lungs, heart, and gastrointestinal tract. By blocking the action of acetylcholine at these receptors, muscarinic antagonists can produce a range of effects depending on the specific receptor subtype that is affected.

For example, muscarinic antagonists may be used to treat conditions such as chronic obstructive pulmonary disease (COPD) and asthma by relaxing the smooth muscle in the airways and reducing bronchoconstriction. They may also be used to treat conditions such as urinary incontinence or overactive bladder by reducing bladder contractions.

Some common muscarinic antagonists include atropine, scopolamine, ipratropium, and tiotropium. It's important to note that these drugs can have significant side effects, including dry mouth, blurred vision, constipation, and confusion, especially when used in high doses or for prolonged periods of time.

Bronchial hyperresponsiveness (BHR) or bronchial hyperreactivity (BH) is a medical term that refers to the increased sensitivity and exaggerated response of the airways to various stimuli. In people with BHR, the airways narrow (constrict) more than usual in response to certain triggers such as allergens, cold air, exercise, or irritants like smoke or fumes. This narrowing can cause symptoms such as wheezing, coughing, chest tightness, and shortness of breath.

BHR is often associated with asthma and other respiratory conditions, including chronic obstructive pulmonary disease (COPD) and bronchiectasis. It is typically diagnosed through a series of tests that measure the degree of airway narrowing in response to various stimuli. These tests may include spirometry, methacholine challenge test, or histamine challenge test.

BHR can be managed with medications such as bronchodilators and anti-inflammatory drugs, which help to relax the muscles around the airways and reduce inflammation. It is also important to avoid triggers that can exacerbate symptoms and make BHR worse.

Helium is not a medical term, but it's a chemical element with symbol He and atomic number 2. It's a colorless, odorless, tasteless, non-toxic, inert, monatomic gas that heads the noble gases section of the periodic table. In medicine, helium is sometimes used in medical settings for its unique properties, such as being less dense than air, which can help improve the delivery of oxygen to patients with respiratory conditions. For example, heliox, a mixture of helium and oxygen, may be used to reduce the work of breathing in patients with conditions like chronic obstructive pulmonary disease (COPD) or asthma. Additionally, helium is also used in cryogenic medical equipment and in magnetic resonance imaging (MRI) machines to cool the superconducting magnets.

Lung compliance is a measure of the ease with which the lungs expand and is defined as the change in lung volume for a given change in transpulmonary pressure. It is often expressed in units of liters per centimeter of water (L/cm H2O). A higher compliance indicates that the lungs are more easily distensible, while a lower compliance suggests that the lungs are stiffer and require more force to expand. Lung compliance can be affected by various conditions such as pulmonary fibrosis, pneumonia, acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary disease (COPD).

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

In the context of medical terminology, "powders" do not have a specific technical definition. However, in a general sense, powders refer to dry, finely ground or pulverized solid substances that can be dispersed in air or liquid mediums. In medicine, powders may include various forms of medications, such as crushed tablets or capsules, which are intended to be taken orally, mixed with liquids, or applied topically. Additionally, certain medical treatments and therapies may involve the use of medicated powders for various purposes, such as drying agents, abrasives, or delivery systems for active ingredients.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

"Pharmaceutical solutions" is a term that refers to medications or drugs that are formulated in a liquid state, as opposed to solid forms like tablets or capsules. These solutions are typically created by dissolving the active pharmaceutical ingredient (API) in a solvent, such as water or ethanol, along with other excipients that help stabilize and preserve the solution.

Pharmaceutical solutions can be administered to patients through various routes, including oral, intravenous, subcutaneous, or intramuscular injection, depending on the desired site of action and the specific properties of the drug. Some examples of pharmaceutical solutions include antibiotic infusions, pain medications, and electrolyte replacement drinks.

It's important to note that the term "pharmaceutical solutions" can also refer more broadly to the process of developing and manufacturing drugs, as well as to the industry as a whole. However, in a medical context, it most commonly refers to liquid medications.

Tachyphylaxis is a medical term that refers to the rapid and temporary loss of response to a drug after its repeated administration, especially when administered in quick succession. This occurs due to the decreased sensitivity or responsiveness of the body's receptors to the drug, resulting in a reduced therapeutic effect over time.

In simpler terms, tachyphylaxis is when the body becomes quickly desensitized to a medication after taking it multiple times in a short period, causing the drug to become less effective or ineffective at achieving the desired outcome. This phenomenon can occur with various medications, including those used for treating pain, allergies, and psychiatric conditions.

It's important to note that tachyphylaxis should not be confused with tolerance, which is a similar but distinct concept where the body gradually becomes less responsive to a drug after prolonged use over time.

Histamine is defined as a biogenic amine that is widely distributed throughout the body and is involved in various physiological functions. It is derived primarily from the amino acid histidine by the action of histidine decarboxylase. Histamine is stored in granules (along with heparin and proteases) within mast cells and basophils, and is released upon stimulation or degranulation of these cells.

Once released into the tissues and circulation, histamine exerts a wide range of pharmacological actions through its interaction with four types of G protein-coupled receptors (H1, H2, H3, and H4 receptors). Histamine's effects are diverse and include modulation of immune responses, contraction and relaxation of smooth muscle, increased vascular permeability, stimulation of gastric acid secretion, and regulation of neurotransmission.

Histamine is also a potent mediator of allergic reactions and inflammation, causing symptoms such as itching, sneezing, runny nose, and wheezing. Antihistamines are commonly used to block the actions of histamine at H1 receptors, providing relief from these symptoms.

Drug labeling refers to the information that is provided on the packaging or container of a medication, as well as any accompanying promotional materials. This information is intended to provide healthcare professionals and patients with accurate and up-to-date data about the drug's composition, intended use, dosage, side effects, contraindications, and other important details that are necessary for safe and effective use.

The labeling of prescription drugs in the United States is regulated by the Food and Drug Administration (FDA), which requires manufacturers to submit proposed labeling as part of their new drug application. The FDA reviews the labeling to ensure that it is truthful, balanced, and not misleading, and provides accurate information about the drug's risks and benefits.

The labeling of over-the-counter (OTC) drugs is also regulated by the FDA, but in this case, the agency has established a set of monographs that specify the conditions under which certain active ingredients can be used and the labeling requirements for each ingredient. Manufacturers of OTC drugs must ensure that their labeling complies with these monographs.

In addition to the information required by regulatory agencies, drug labeling may also include additional information provided by the manufacturer, such as detailed instructions for use, storage requirements, and any warnings or precautions that are necessary to ensure safe and effective use of the medication. It is important for healthcare professionals and patients to carefully review and understand all of the information provided on a drug's labeling before using the medication.

Cromolyn sodium is a medication that belongs to a class of drugs known as mast cell stabilizers. It works by preventing the release of certain chemicals from mast cells, which are immune system cells found in various tissues throughout the body, including the skin, lungs, and gastrointestinal tract.

Mast cells play an important role in the body's allergic response. When a person is exposed to an allergen, such as pollen or pet dander, mast cells release chemicals like histamine, which can cause symptoms of an allergic reaction, such as itching, swelling, and inflammation.

Cromolyn sodium is used to prevent asthma attacks, hay fever, and other allergic reactions. It is often prescribed for people who have difficulty controlling their symptoms with other medications, such as inhaled corticosteroids or antihistamines.

The medication is available in various forms, including inhalers, nasal sprays, and eye drops. When used as an inhaler, cromolyn sodium is typically administered four times a day to prevent asthma symptoms. As a nasal spray or eye drop, it is usually used several times a day to prevent allergic rhinitis or conjunctivitis.

While cromolyn sodium can be effective in preventing allergic reactions, it does not provide immediate relief of symptoms. It may take several days or even weeks of regular use before the full benefits of the medication are felt.

'Amaranthus' is the scientific name for a genus of plants that includes around 60-75 species, many of which are commonly known as amaranths. These plants belong to the family Amaranthaceae and are native to both temperate and tropical regions around the world. Some amaranth species are grown for their edible leaves and seeds, while others are cultivated as ornamental plants due to their attractive foliage and flowers.

The term 'Amaranthus' does not have a specific medical definition, but some amaranth species do have various health benefits and uses. For instance, the seeds of certain amaranth species are rich in protein, fiber, and essential minerals like iron, magnesium, and manganese. They also contain a good amount of lysine, an essential amino acid that is often lacking in cereal grains. As a result, amaranth seeds have been used as a nutritious food source in many cultures throughout history.

Additionally, some research suggests that certain amaranth extracts may possess medicinal properties. For example, a study published in the Journal of Ethnopharmacology found that an ethanolic extract of Amaranthus retroflexus (a common weed known as redroot pigweed) exhibited antioxidant and anti-inflammatory activities in vitro. However, more research is needed to confirm these potential health benefits and determine the safety and efficacy of amaranth-based treatments.

Drug packaging refers to the process and materials used to enclose, protect, and provide information about a pharmaceutical product. The package may include the container for the medication, such as a bottle or blister pack, as well as any accompanying leaflets or inserts that contain details about the drug's dosage, side effects, and proper use.

The packaging of drugs serves several important functions:

1. Protection: Proper packaging helps to protect the medication from physical damage, contamination, and degradation due to exposure to light, moisture, or air.
2. Child-resistance: Many drug packages are designed to be child-resistant, meaning they are difficult for young children to open but can still be easily accessed by adults.
3. Tamper-evidence: Packaging may also include features that make it easy to detect if the package has been tampered with or opened without authorization.
4. Labeling: Drug packaging must comply with regulatory requirements for labeling, including providing clear and accurate information about the drug's ingredients, dosage, warnings, and precautions.
5. Unit-dose packaging: Some drugs are packaged in unit-dose form, which means that each dose is individually wrapped or sealed in a separate package. This can help to reduce medication errors and ensure that patients receive the correct dosage.
6. Branding and marketing: Drug packaging may also serve as a tool for branding and marketing the product, with distinctive colors, shapes, and graphics that help to differentiate it from similar products.

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Chronic bronchitis is a long-term inflammation of the airways (bronchi) in the lungs. It is characterized by a persistent cough that produces excessive mucus or sputum. The cough and mucus production must be present for at least three months in two consecutive years to meet the diagnostic criteria for chronic bronchitis.

The inflammation of the airways can lead to narrowing, obstructing the flow of air into and out of the lungs, resulting in shortness of breath and wheezing. Chronic bronchitis is often associated with exposure to irritants such as tobacco smoke, dust, or chemical fumes over an extended period.

It is a significant component of chronic obstructive pulmonary disease (COPD), which also includes emphysema. While there is no cure for chronic bronchitis, treatments can help alleviate symptoms and slow the progression of the disease. These may include bronchodilators, corticosteroids, and pulmonary rehabilitation. Quitting smoking is crucial in managing this condition.

Procaterol is not a medication that has been approved by the US Food and Drug Administration (FDA) for use in the United States. However, it is a medication that is available in some other countries as a bronchodilator, which is a type of medication that is used to open up the airways in the lungs and make it easier to breathe.

Procaterol belongs to a class of medications called long-acting beta-agonists (LABAs). LABAs work by relaxing the muscles in the airways and increasing the size of the airways, which makes it easier for air to flow in and out of the lungs. Procaterol is often used to prevent symptoms of chronic obstructive pulmonary disease (COPD), such as shortness of breath and coughing.

It's important to note that procaterol has been associated with an increased risk of asthma-related deaths, so it should only be used under the close supervision of a healthcare professional and should not be used in people with asthma who are not also using a corticosteroid inhaler.

Drug tolerance is a medical concept that refers to the decreased response to a drug following its repeated use, requiring higher doses to achieve the same effect. This occurs because the body adapts to the presence of the drug, leading to changes in the function or expression of targets that the drug acts upon, such as receptors or enzymes. Tolerance can develop to various types of drugs, including opioids, benzodiazepines, and alcohol, and it is often associated with physical dependence and addiction. It's important to note that tolerance is different from resistance, which refers to the ability of a pathogen to survive or grow in the presence of a drug, such as antibiotics.

Clinical trials are research studies that involve human participants and are designed to evaluate the safety and efficacy of new medical treatments, drugs, devices, or behavioral interventions. The purpose of clinical trials is to determine whether a new intervention is safe, effective, and beneficial for patients, as well as to compare it with currently available treatments. Clinical trials follow a series of phases, each with specific goals and criteria, before a new intervention can be approved by regulatory authorities for widespread use.

Clinical trials are conducted according to a protocol, which is a detailed plan that outlines the study's objectives, design, methodology, statistical analysis, and ethical considerations. The protocol is developed and reviewed by a team of medical experts, statisticians, and ethicists, and it must be approved by an institutional review board (IRB) before the trial can begin.

Participation in clinical trials is voluntary, and participants must provide informed consent before enrolling in the study. Informed consent involves providing potential participants with detailed information about the study's purpose, procedures, risks, benefits, and alternatives, as well as their rights as research subjects. Participants can withdraw from the study at any time without penalty or loss of benefits to which they are entitled.

Clinical trials are essential for advancing medical knowledge and improving patient care. They help researchers identify new treatments, diagnostic tools, and prevention strategies that can benefit patients and improve public health. However, clinical trials also pose potential risks to participants, including adverse effects from experimental interventions, time commitment, and inconvenience. Therefore, it is important for researchers to carefully design and conduct clinical trials to minimize risks and ensure that the benefits outweigh the risks.

A "Drug Administration Schedule" refers to the plan for when and how a medication should be given to a patient. It includes details such as the dose, frequency (how often it should be taken), route (how it should be administered, such as orally, intravenously, etc.), and duration (how long it should be taken) of the medication. This schedule is often created and prescribed by healthcare professionals, such as doctors or pharmacists, to ensure that the medication is taken safely and effectively. It may also include instructions for missed doses or changes in the dosage.

Histamine antagonists, also known as histamine blockers or H1-blockers, are a class of medications that work by blocking the action of histamine, a substance in the body that is released during an allergic reaction. Histamine causes many of the symptoms of an allergic response, such as itching, sneezing, runny nose, and hives. By blocking the effects of histamine, these medications can help to relieve or prevent allergy symptoms.

Histamine antagonists are often used to treat conditions such as hay fever, hives, and other allergic reactions. They may also be used to treat stomach ulcers caused by excessive production of stomach acid. Some examples of histamine antagonists include diphenhydramine (Benadryl), loratadine (Claritin), and famotidine (Pepcid).

It's important to note that while histamine antagonists can be effective at relieving allergy symptoms, they do not cure allergies or prevent the release of histamine. They simply block its effects. It's also worth noting that these medications can have side effects, such as drowsiness, dry mouth, and dizziness, so it's important to follow your healthcare provider's instructions carefully when taking them.

Exercise-induced asthma (EIA) is a type of asthma that is triggered by physical activity or exercise. Officially known as exercise-induced bronchoconstriction (EIB), this condition causes the airways in the lungs to narrow and become inflamed, leading to symptoms such as wheezing, coughing, shortness of breath, and chest tightness. These symptoms typically occur during or after exercise and can last for several minutes to a few hours.

EIA is caused by the loss of heat and moisture from the airways during exercise, which leads to the release of inflammatory mediators that cause the airways to constrict. People with EIA may have underlying asthma or may only experience symptoms during exercise. Proper diagnosis and management of EIA can help individuals maintain an active lifestyle and participate in physical activities without experiencing symptoms.

Isoproterenol is a medication that belongs to a class of drugs called beta-adrenergic agonists. Medically, it is defined as a synthetic catecholamine with both alpha and beta adrenergic receptor stimulating properties. It is primarily used as a bronchodilator to treat conditions such as asthma and chronic obstructive pulmonary disease (COPD) by relaxing the smooth muscles in the airways, thereby improving breathing.

Isoproterenol can also be used in the treatment of bradycardia (abnormally slow heart rate), cardiac arrest, and heart blocks by increasing the heart rate and contractility. However, due to its non-selective beta-agonist activity, it may cause various side effects such as tremors, palpitations, and increased blood pressure. Its use is now limited due to the availability of more selective and safer medications.

I must clarify that the term "Guinea Pigs" is not typically used in medical definitions. However, in colloquial or informal language, it may refer to people who are used as the first to try out a new medical treatment or drug. This is known as being a "test subject" or "in a clinical trial."

In the field of scientific research, particularly in studies involving animals, guinea pigs are small rodents that are often used as experimental subjects due to their size, cost-effectiveness, and ease of handling. They are not actually pigs from Guinea, despite their name's origins being unclear. However, they do not exactly fit the description of being used in human medical experiments.

Ephedrine is a medication that stimulates the nervous system and is used to treat low blood pressure, asthma, and nasal congestion. It works by narrowing the blood vessels and increasing heart rate, which can help to increase blood pressure and open up the airways in the lungs. Ephedrine may also be used as a bronchodilator to treat COPD (chronic obstructive pulmonary disease).

Ephedrine is available in various forms, including tablets, capsules, and solutions for injection. It is important to follow the instructions of a healthcare provider when taking ephedrine, as it can have side effects such as rapid heart rate, anxiety, headache, and dizziness. Ephedrine should not be used by people with certain medical conditions, such as heart disease, high blood pressure, or narrow-angle glaucoma, and it should not be taken during pregnancy or breastfeeding without consulting a healthcare provider.

In addition to its medical uses, ephedrine has been used as a performance-enhancing drug and is banned by many sports organizations. It can also be found in some over-the-counter cold and allergy medications, although these products are required to carry warnings about the potential for misuse and addiction.

Racepinephrine is not typically referred to as a "race" in the medical context, but rather as a form of epinephrine (also known as adrenaline). Racepinephrine is the optical isomer of epinephrine, meaning that it is a molecule with the same chemical formula but a different arrangement of atoms in space.

Racepinephrine is a naturally occurring catecholamine, a type of neurotransmitter and hormone that is produced by the adrenal glands and is involved in the "fight or flight" response. It is also used as a medication, typically in the form of the racemic mixture of epinephrine, which contains equal amounts of both isomers (R- and S-epinephrine).

Racepinephrine has similar effects to epinephrine, including increasing heart rate and blood pressure, improving respiratory function, and enhancing mental alertness. It is used in the treatment of anaphylaxis, cardiac arrest, and other emergency situations where rapid restoration of cardiovascular function is necessary.

It's important to note that while racepinephrine and epinephrine have similar effects, they are not identical and may have different therapeutic uses and potential side effects.

Whole-body plethysmography is a non-invasive medical technique used to measure changes in the volume of air in the lungs and chest during breathing. It is often utilized in the diagnosis and assessment of various respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and restrictive lung diseases.

During whole-body plethysmography, the patient enters a sealed, clear chamber, usually in a standing or sitting position. The patient is instructed to breathe normally while the machine measures changes in pressure within the chamber as the chest and abdomen move during respiration. These measurements are then used to calculate lung volume, airflow, and other respiratory parameters.

This technique provides valuable information about the functional status of the lungs and can help healthcare providers make informed decisions regarding diagnosis, treatment planning, and disease monitoring.

Air filters are devices used to remove contaminants and impurities from the air. They work by trapping particles that flow through them, such as dust, pollen, mold spores, and bacteria. Air filters are often used in heating, ventilation, and air conditioning (HVAC) systems to improve indoor air quality. They can also be found in portable air cleaners and vacuum cleaners.

Air filters are typically made of a porous material such as fiberglass, cotton, or paper, which is designed to trap particles of different sizes. The efficiency of an air filter is measured by its Minimum Efficiency Reporting Value (MERV) rating, which ranges from 1 to 16, with higher ratings indicating better filtration performance.

Medical-grade air filters, such as High Efficiency Particulate Air (HEPA) filters, are designed to remove at least 99.97% of particles that are 0.3 microns or larger in diameter. These filters are commonly used in hospitals and medical facilities to help prevent the spread of infectious diseases.

Lung volume measurements are clinical tests that determine the amount of air inhaled, exhaled, and present in the lungs at different times during the breathing cycle. These measurements include:

1. Tidal Volume (TV): The amount of air inhaled or exhaled during normal breathing, usually around 500 mL in resting adults.
2. Inspiratory Reserve Volume (IRV): The additional air that can be inhaled after a normal inspiration, approximately 3,000 mL in adults.
3. Expiratory Reserve Volume (ERV): The extra air that can be exhaled after a normal expiration, about 1,000-1,200 mL in adults.
4. Residual Volume (RV): The air remaining in the lungs after a maximal exhalation, approximately 1,100-1,500 mL in adults.
5. Total Lung Capacity (TLC): The total amount of air the lungs can hold at full inflation, calculated as TV + IRV + ERV + RV, around 6,000 mL in adults.
6. Functional Residual Capacity (FRC): The volume of air remaining in the lungs after a normal expiration, equal to ERV + RV, about 2,100-2,700 mL in adults.
7. Inspiratory Capacity (IC): The maximum amount of air that can be inhaled after a normal expiration, equal to TV + IRV, around 3,500 mL in adults.
8. Vital Capacity (VC): The total volume of air that can be exhaled after a maximal inspiration, calculated as IC + ERV, approximately 4,200-5,600 mL in adults.

These measurements help assess lung function and identify various respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and restrictive lung diseases.

Leukotriene antagonists are a class of medications that work by blocking the action of leukotrienes, which are chemicals released by the immune system in response to an allergen or irritant. Leukotrienes cause airway muscles to tighten and inflammation in the airways, leading to symptoms such as wheezing, shortness of breath, and coughing. By blocking the action of leukotrienes, leukotriene antagonists can help relieve these symptoms and improve lung function. These medications are often used to treat asthma and allergic rhinitis (hay fever). Examples of leukotriene antagonists include montelukast, zafirlukast, and pranlukast.

Prostanoic acids are a type of fatty acid that are produced naturally in the body as part of the prostaglandin metabolic pathway. They are derived from arachidonic acid, a type of omega-6 fatty acid, and are involved in various physiological processes such as inflammation, blood flow regulation, and platelet aggregation. Prostanoic acids include compounds such as prostaglandin E2 (PGE2), prostaglandin F2α (PGF2α), prostacyclin (PGI2), and thromboxane A2 (TXA2). These compounds act as signaling molecules, binding to specific receptors on the surface of cells and triggering a variety of cellular responses. They are synthesized and released by cells in response to various stimuli, such as injury or infection, and play important roles in the body's response to these stressors.

Nonprescription drugs, also known as over-the-counter (OTC) drugs, are medications that can be legally purchased without a prescription from a healthcare professional. They are considered safe and effective for treating minor illnesses or symptoms when used according to the directions on the label. Examples include pain relievers like acetaminophen and ibuprofen, antihistamines for allergies, and topical treatments for skin conditions. It is still important to follow the recommended dosage and consult with a healthcare provider if there are any concerns or questions about using nonprescription drugs.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

A placebo is a substance or treatment that has no inherent therapeutic effect. It is often used in clinical trials as a control against which the effects of a new drug or therapy can be compared. Placebos are typically made to resemble the active treatment, such as a sugar pill for a medication trial, so that participants cannot tell the difference between what they are receiving and the actual treatment.

The placebo effect refers to the phenomenon where patients experience real improvements in their symptoms or conditions even when given a placebo. This may be due to psychological factors such as belief in the effectiveness of the treatment, suggestion, or conditioning. The placebo effect is often used as a comparison group in clinical trials to help determine if the active treatment has a greater effect than no treatment at all.

Bronchiolitis is a common respiratory infection in infants and young children, typically caused by a viral infection. It is characterized by inflammation and congestion of the bronchioles (the smallest airways in the lungs), which can lead to difficulty breathing and wheezing.

The most common virus that causes bronchiolitis is respiratory syncytial virus (RSV), but other viruses such as rhinovirus, influenza, and parainfluenza can also cause the condition. Symptoms of bronchiolitis may include cough, wheezing, rapid breathing, difficulty feeding, and fatigue.

In severe cases, bronchiolitis can lead to respiratory distress and require hospitalization. Treatment typically involves supportive care, such as providing fluids and oxygen therapy, and in some cases, medications to help open the airways may be used. Prevention measures include good hand hygiene and avoiding close contact with individuals who are sick.

Adrenergic receptors are a type of G protein-coupled receptor that bind and respond to catecholamines, such as epinephrine (adrenaline) and norepinephrine (noradrenaline). Beta-2 adrenergic receptors (β2-ARs) are a subtype of adrenergic receptors that are widely distributed throughout the body, particularly in the lungs, heart, blood vessels, gastrointestinal tract, and skeletal muscle.

When β2-ARs are activated by catecholamines, they trigger a range of physiological responses, including relaxation of smooth muscle, increased heart rate and contractility, bronchodilation, and inhibition of insulin secretion. These effects are mediated through the activation of intracellular signaling pathways involving G proteins and second messengers such as cyclic AMP (cAMP).

β2-ARs have been a major focus of drug development for various medical conditions, including asthma, chronic obstructive pulmonary disease (COPD), heart failure, hypertension, and anxiety disorders. Agonists of β2-ARs, such as albuterol and salmeterol, are commonly used to treat asthma and COPD by relaxing bronchial smooth muscle and reducing airway obstruction. Antagonists of β2-ARs, such as propranolol, are used to treat hypertension, angina, and heart failure by blocking the effects of catecholamines on the heart and blood vessels.

Expiratory Reserve Volume (ERV) is the maximum amount of air that can be exhaled forcefully after a normal tidal exhalation. It is the difference between the functional residual capacity (FRC) and the residual volume (RV). In other words, ERV is the extra volume of air that can be exhaled from the lungs after a normal breath out, when one tries to empty the lungs as much as possible. This volume is an important parameter in pulmonary function tests and helps assess lung health and disease. A decreased ERV may indicate restrictive lung diseases such as pulmonary fibrosis or neuromuscular disorders affecting respiratory muscles.

Respiratory disorders are a group of conditions that affect the respiratory system, including the nose, throat (pharynx), windpipe (trachea), bronchi, lungs, and diaphragm. These disorders can make it difficult for a person to breathe normally and may cause symptoms such as coughing, wheezing, shortness of breath, and chest pain.

There are many different types of respiratory disorders, including:

1. Asthma: A chronic inflammatory disease that causes the airways to become narrow and swollen, leading to difficulty breathing.
2. Chronic obstructive pulmonary disease (COPD): A group of lung diseases, including emphysema and chronic bronchitis, that make it hard to breathe.
3. Pneumonia: An infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
4. Lung cancer: A type of cancer that forms in the tissues of the lungs and can cause symptoms such as coughing, chest pain, and shortness of breath.
5. Tuberculosis (TB): A bacterial infection that mainly affects the lungs but can also affect other parts of the body.
6. Sleep apnea: A disorder that causes a person to stop breathing for short periods during sleep.
7. Interstitial lung disease: A group of disorders that cause scarring of the lung tissue, leading to difficulty breathing.
8. Pulmonary fibrosis: A type of interstitial lung disease that causes scarring of the lung tissue and makes it hard to breathe.
9. Pleural effusion: An abnormal accumulation of fluid in the space between the lungs and chest wall.
10. Lung transplantation: A surgical procedure to replace a diseased or failing lung with a healthy one from a donor.

Respiratory disorders can be caused by a variety of factors, including genetics, exposure to environmental pollutants, smoking, and infections. Treatment for respiratory disorders may include medications, oxygen therapy, breathing exercises, and lifestyle changes. In some cases, surgery may be necessary to treat the disorder.

"Myrtus" is a botanical name that refers to a genus of evergreen shrubs and trees in the family Myrtaceae. The most common species is Myrtus communis, also known as the common myrtle or European myrtle. It is native to the Mediterranean region and has been used in traditional medicine for various purposes.

In a medical context, "Myrtus" may be mentioned in relation to herbal remedies or phytotherapy, where extracts from the leaves, flowers, or fruits of the plant are used. Some studies suggest that Myrtus communis may have anti-inflammatory, antimicrobial, and antioxidant properties. However, more research is needed to confirm these effects and establish safe and effective therapeutic dosages.

It's important to note that while some natural substances can be beneficial for health, they should not be used as a substitute for professional medical advice or treatment. Always consult with a healthcare provider before starting any new supplement regimen.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

Glucocorticoids are a class of steroid hormones that are naturally produced in the adrenal gland, or can be synthetically manufactured. They play an essential role in the metabolism of carbohydrates, proteins, and fats, and have significant anti-inflammatory effects. Glucocorticoids suppress immune responses and inflammation by inhibiting the release of inflammatory mediators from various cells, such as mast cells, eosinophils, and lymphocytes. They are frequently used in medical treatment for a wide range of conditions, including allergies, asthma, rheumatoid arthritis, dermatological disorders, and certain cancers. Prolonged use or high doses of glucocorticoids can lead to several side effects, such as weight gain, mood changes, osteoporosis, and increased susceptibility to infections.

Respiratory physiological phenomena refer to the various mechanical, chemical, and biological processes and functions that occur in the respiratory system during breathing and gas exchange. These phenomena include:

1. Ventilation: The movement of air into and out of the lungs, which is achieved through the contraction and relaxation of the diaphragm and intercostal muscles.
2. Gas Exchange: The diffusion of oxygen (O2) from the alveoli into the bloodstream and carbon dioxide (CO2) from the bloodstream into the alveoli.
3. Respiratory Mechanics: The physical properties and forces that affect the movement of air in and out of the lungs, such as lung compliance, airway resistance, and chest wall elasticity.
4. Control of Breathing: The regulation of ventilation by the central nervous system through the integration of sensory information from chemoreceptors and mechanoreceptors in the respiratory system.
5. Acid-Base Balance: The maintenance of a stable pH level in the blood through the regulation of CO2 elimination and bicarbonate balance by the respiratory and renal systems.
6. Oxygen Transport: The binding of O2 to hemoglobin in the red blood cells and its delivery to the tissues for metabolic processes.
7. Defense Mechanisms: The various protective mechanisms that prevent the entry and colonization of pathogens and foreign particles into the respiratory system, such as mucociliary clearance, cough reflex, and immune responses.

Plethysmography is a non-invasive medical technique used to measure changes in volume or blood flow within an organ or body part, typically in the lungs or extremities. There are several types of plethysmography, including:

1. **Whole Body Plethysmography (WBP):** This type of plethysmography is used to assess lung function and volumes by measuring changes in pressure within a sealed chamber that contains the patient's entire body except for their head. The patient breathes normally while wearing a nose clip, allowing technicians to analyze respiratory patterns, airflow, and lung volume changes.
2. **Segmental or Local Plethysmography:** This technique measures volume or blood flow changes in specific body parts, such as the limbs or digits. It can help diagnose and monitor conditions affecting peripheral circulation, like deep vein thrombosis, arterial occlusive disease, or Raynaud's phenomenon.
3. **Impedance Plethysmography (IPG):** This non-invasive method uses electrical impedance to estimate changes in blood volume within an organ or body part. By applying a small electrical current and measuring the opposition to flow (impedance), technicians can determine variations in blood volume, which can help diagnose conditions like deep vein thrombosis or heart failure.
4. **Optical Plethysmography:** This technique uses light to measure changes in blood volume, typically in the skin or mucous membranes. By shining a light on the area and analyzing the reflected or transmitted light, technicians can detect variations in blood volume related to cardiac output, respiration, or other physiological factors.

Overall, plethysmography is an essential tool for diagnosing and monitoring various medical conditions affecting circulation, respiratory function, and organ volumes.

An acute disease is a medical condition that has a rapid onset, develops quickly, and tends to be short in duration. Acute diseases can range from minor illnesses such as a common cold or flu, to more severe conditions such as pneumonia, meningitis, or a heart attack. These types of diseases often have clear symptoms that are easy to identify, and they may require immediate medical attention or treatment.

Acute diseases are typically caused by an external agent or factor, such as a bacterial or viral infection, a toxin, or an injury. They can also be the result of a sudden worsening of an existing chronic condition. In general, acute diseases are distinct from chronic diseases, which are long-term medical conditions that develop slowly over time and may require ongoing management and treatment.

Examples of acute diseases include:

* Acute bronchitis: a sudden inflammation of the airways in the lungs, often caused by a viral infection.
* Appendicitis: an inflammation of the appendix that can cause severe pain and requires surgical removal.
* Gastroenteritis: an inflammation of the stomach and intestines, often caused by a viral or bacterial infection.
* Migraine headaches: intense headaches that can last for hours or days, and are often accompanied by nausea, vomiting, and sensitivity to light and sound.
* Myocardial infarction (heart attack): a sudden blockage of blood flow to the heart muscle, often caused by a buildup of plaque in the coronary arteries.
* Pneumonia: an infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
* Sinusitis: an inflammation of the sinuses, often caused by a viral or bacterial infection.

It's important to note that while some acute diseases may resolve on their own with rest and supportive care, others may require medical intervention or treatment to prevent complications and promote recovery. If you are experiencing symptoms of an acute disease, it is always best to seek medical attention to ensure proper diagnosis and treatment.

S-Nitrosoglutathione (GSNO) is defined as a type of nitrosothiol, which is a class of compounds containing a nitroso (−NO) group attached to a sulfur atom. Specifically, GSNO is the result of the attachment of a nitric oxide (NO) molecule to the sulfur atom of the tripeptide glutathione (GSH). This compound has been the subject of extensive research due to its potential role in the regulation of various biological processes, including cell signaling, vasodilation, and neurotransmission, among others. It is also known to have antioxidant properties and to play a role in the immune response. However, it should be noted that abnormal levels of GSNO have been associated with various pathological conditions, such as cancer, neurodegenerative diseases, and cardiovascular disorders.

Oxygen inhalation therapy is a medical treatment that involves the administration of oxygen to a patient through a nasal tube or mask, with the purpose of increasing oxygen concentration in the body. This therapy is used to treat various medical conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, heart failure, and other conditions that cause low levels of oxygen in the blood. The additional oxygen helps to improve tissue oxygenation, reduce work of breathing, and promote overall patient comfort and well-being. Oxygen therapy may be delivered continuously or intermittently, depending on the patient's needs and medical condition.

Methacholine compounds are medications that are used as a diagnostic tool to help identify and confirm the presence of airway hyperresponsiveness in patients with respiratory symptoms such as cough, wheeze, or shortness of breath. These compounds act as bronchoconstrictors, causing narrowing of the airways in individuals who have heightened sensitivity and reactivity of their airways, such as those with asthma.

Methacholine is a synthetic derivative of acetylcholine, a neurotransmitter that mediates nerve impulse transmission in the body. When inhaled, methacholine binds to muscarinic receptors on the smooth muscle surrounding the airways, leading to their contraction and narrowing. The degree of bronchoconstriction is then measured to assess the patient's airway responsiveness.

It is important to note that methacholine compounds are not used as therapeutic agents but rather as diagnostic tools in a controlled medical setting under the supervision of healthcare professionals.

A drug combination refers to the use of two or more drugs in combination for the treatment of a single medical condition or disease. The rationale behind using drug combinations is to achieve a therapeutic effect that is superior to that obtained with any single agent alone, through various mechanisms such as:

* Complementary modes of action: When different drugs target different aspects of the disease process, their combined effects may be greater than either drug used alone.
* Synergistic interactions: In some cases, the combination of two or more drugs can result in a greater-than-additive effect, where the total response is greater than the sum of the individual responses to each drug.
* Antagonism of adverse effects: Sometimes, the use of one drug can mitigate the side effects of another, allowing for higher doses or longer durations of therapy.

Examples of drug combinations include:

* Highly active antiretroviral therapy (HAART) for HIV infection, which typically involves a combination of three or more antiretroviral drugs to suppress viral replication and prevent the development of drug resistance.
* Chemotherapy regimens for cancer treatment, where combinations of cytotoxic agents are used to target different stages of the cell cycle and increase the likelihood of tumor cell death.
* Fixed-dose combination products, such as those used in the treatment of hypertension or type 2 diabetes, which combine two or more active ingredients into a single formulation for ease of administration and improved adherence to therapy.

However, it's important to note that drug combinations can also increase the risk of adverse effects, drug-drug interactions, and medication errors. Therefore, careful consideration should be given to the selection of appropriate drugs, dosing regimens, and monitoring parameters when using drug combinations in clinical practice.

Phosphodiesterase 4 inhibitors (PDE4 inhibitors) are a class of drugs that work by increasing the levels of cyclic adenosine monophosphate (cAMP) in cells. They do this by blocking the phosphodiesterase 4 enzyme, which is responsible for breaking down cAMP.

Cyclic AMP is an important intracellular signaling molecule that plays a role in various physiological processes, including inflammation and immune response. By increasing cAMP levels, PDE4 inhibitors can help to reduce inflammation and modulate the immune system.

PDE4 inhibitors have been studied for their potential therapeutic benefits in a range of conditions, including asthma, COPD, psoriasis, atopic dermatitis, and depression. Some examples of PDE4 inhibitors include roflumilast, apremilast, crisaborole, and ditropan.

It's important to note that while PDE4 inhibitors have shown promise in clinical trials, they can also have side effects, such as gastrointestinal symptoms, headache, and dizziness. Additionally, their long-term safety and efficacy are still being studied.

Aminopyridines are a group of organic compounds that contain an amino group (-NH2) attached to a pyridine ring, which is a six-membered aromatic heterocycle containing one nitrogen atom. Aminopyridines have various pharmacological properties and are used in the treatment of several medical conditions.

The most commonly used aminopyridines in medicine include:

1. 4-Aminopyridine (also known as Fampridine): It is a potassium channel blocker that is used to improve walking ability in patients with multiple sclerosis (MS) and other neurological disorders. It works by increasing the conduction of nerve impulses in demyelinated nerves, thereby improving muscle strength and coordination.
2. 3,4-Diaminopyridine: It is a potassium channel blocker that is used to treat Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disorder characterized by muscle weakness. It works by increasing the release of acetylcholine from nerve endings, thereby improving muscle strength and function.
3. 2-Aminopyridine: It is an experimental drug that has been studied for its potential use in treating various neurological disorders, including MS, Parkinson's disease, and stroke. It works by increasing the release of neurotransmitters from nerve endings, thereby improving neuronal communication.

Like all medications, aminopyridines can have side effects, including gastrointestinal symptoms, headache, dizziness, and in rare cases, seizures. It is important to use these drugs under the supervision of a healthcare provider and follow their dosage instructions carefully.

Medical Definition of Respiration:

Respiration, in physiology, is the process by which an organism takes in oxygen and gives out carbon dioxide. It's also known as breathing. This process is essential for most forms of life because it provides the necessary oxygen for cellular respiration, where the cells convert biochemical energy from nutrients into adenosine triphosphate (ATP), and releases waste products, primarily carbon dioxide.

In humans and other mammals, respiration is a two-stage process:

1. Breathing (or external respiration): This involves the exchange of gases with the environment. Air enters the lungs through the mouth or nose, then passes through the pharynx, larynx, trachea, and bronchi, finally reaching the alveoli where the actual gas exchange occurs. Oxygen from the inhaled air diffuses into the blood, while carbon dioxide, a waste product of metabolism, diffuses from the blood into the alveoli to be exhaled.

2. Cellular respiration (or internal respiration): This is the process by which cells convert glucose and other nutrients into ATP, water, and carbon dioxide in the presence of oxygen. The carbon dioxide produced during this process then diffuses out of the cells and into the bloodstream to be exhaled during breathing.

In summary, respiration is a vital physiological function that enables organisms to obtain the necessary oxygen for cellular metabolism while eliminating waste products like carbon dioxide.

Thiorphan is not a medical condition or disease, but rather a synthetic medication. It is a potent inhibitor of membrane-bound metalloendopeptidases, also known as neprilysin enzymes. These enzymes are responsible for breaking down certain peptides in the body, including some hormones and neurotransmitters.

Thiorphan has been used in research to study the role of these enzymes in various physiological processes. It is also being investigated as a potential therapeutic agent for conditions such as hypertension, heart failure, and Alzheimer's disease. However, it is not currently approved for clinical use in humans.

Therefore, there is no medical definition of 'Thiorphan' as a condition or disease.

I'm sorry for any confusion, but "Management Information Systems" (MIS) is not a medical term. It is a term commonly used in the field of information systems and technology to describe:

"A computer-based system that provides information to support managerial decision-making at all levels of an organization." (Source: "Management Information Systems" article, *Encyclopedia Britannica*)

In a healthcare setting, MIS can be used to manage various aspects of patient care and administrative tasks. This can include maintaining electronic health records, managing scheduling and billing systems, tracking inventory, analyzing patient data for quality improvement, and more.

Respiratory mechanics refers to the biomechanical properties and processes that involve the movement of air through the respiratory system during breathing. It encompasses the mechanical behavior of the lungs, chest wall, and the muscles of respiration, including the diaphragm and intercostal muscles.

Respiratory mechanics includes several key components:

1. **Compliance**: The ability of the lungs and chest wall to expand and recoil during breathing. High compliance means that the structures can easily expand and recoil, while low compliance indicates greater resistance to expansion and recoil.
2. **Resistance**: The opposition to airflow within the respiratory system, primarily due to the friction between the air and the airway walls. Airway resistance is influenced by factors such as airway diameter, length, and the viscosity of the air.
3. **Lung volumes and capacities**: These are the amounts of air present in the lungs during different phases of the breathing cycle. They include tidal volume (the amount of air inspired or expired during normal breathing), inspiratory reserve volume (additional air that can be inspired beyond the tidal volume), expiratory reserve volume (additional air that can be exhaled beyond the tidal volume), and residual volume (the air remaining in the lungs after a forced maximum exhalation).
4. **Work of breathing**: The energy required to overcome the resistance and elastic forces during breathing. This work is primarily performed by the respiratory muscles, which contract to generate negative intrathoracic pressure and expand the chest wall, allowing air to flow into the lungs.
5. **Pressure-volume relationships**: These describe how changes in lung volume are associated with changes in pressure within the respiratory system. Important pressure components include alveolar pressure (the pressure inside the alveoli), pleural pressure (the pressure between the lungs and the chest wall), and transpulmonary pressure (the difference between alveolar and pleural pressures).

Understanding respiratory mechanics is crucial for diagnosing and managing various respiratory disorders, such as chronic obstructive pulmonary disease (COPD), asthma, and restrictive lung diseases.

Hypersensitivity, Immediate: Also known as Type I hypersensitivity, it is an exaggerated and abnormal immune response that occurs within minutes to a few hours after exposure to a second dose of an allergen (a substance that triggers an allergic reaction). This type of hypersensitivity is mediated by immunoglobulin E (IgE) antibodies, which are produced by the immune system in response to the first exposure to the allergen. Upon subsequent exposures, these IgE antibodies bind to mast cells and basophils, leading to their degranulation and the release of mediators such as histamine, leukotrienes, and prostaglandins. These mediators cause a variety of symptoms, including itching, swelling, redness, and pain at the site of exposure, as well as systemic symptoms such as difficulty breathing, wheezing, and hypotension (low blood pressure). Examples of immediate hypersensitivity reactions include allergic asthma, hay fever, anaphylaxis, and some forms of food allergy.

Smooth muscle, also known as involuntary muscle, is a type of muscle that is controlled by the autonomic nervous system and functions without conscious effort. These muscles are found in the walls of hollow organs such as the stomach, intestines, bladder, and blood vessels, as well as in the eyes, skin, and other areas of the body.

Smooth muscle fibers are shorter and narrower than skeletal muscle fibers and do not have striations or sarcomeres, which give skeletal muscle its striped appearance. Smooth muscle is controlled by the autonomic nervous system through the release of neurotransmitters such as acetylcholine and norepinephrine, which bind to receptors on the smooth muscle cells and cause them to contract or relax.

Smooth muscle plays an important role in many physiological processes, including digestion, circulation, respiration, and elimination. It can also contribute to various medical conditions, such as hypertension, gastrointestinal disorders, and genitourinary dysfunction, when it becomes overactive or underactive.

Intermittent Positive-Pressure Breathing (IPPB) is a type of ventilatory support that involves the intermittent delivery of positive pressure to the airways and alveoli during inspiration, while allowing for expiration to occur passively. This technique is often used in medical settings to assist patients with respiratory insufficiency or failure, such as those with chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or following surgery.

During IPPB, the patient breathes in through a mouthpiece or mask that is connected to a ventilator or breathing machine. The machine delivers positive pressure to the airways, which helps to inflate the lungs and improve oxygenation. The pressure can be adjusted to meet the needs of each individual patient, and the frequency and duration of breaths can also be controlled by the healthcare provider.

IPPB is typically used on a short-term basis, as a means of providing respiratory support while a patient's underlying condition improves. It may be used in conjunction with other therapies, such as bronchodilators or corticosteroids, to help improve lung function and reduce symptoms. While IPPB can be an effective tool for managing respiratory insufficiency, it is not without risks, and careful monitoring is required to ensure that it is used safely and effectively.

Cyclopropanes are a class of organic compounds that contain a cyclic structure consisting of three carbon atoms joined by single bonds, forming a three-membered ring. The strain in the cyclopropane ring is due to the fact that the ideal tetrahedral angle at each carbon atom (109.5 degrees) cannot be achieved in a three-membered ring, leading to significant angular strain.

Cyclopropanes are important in organic chemistry because of their unique reactivity and synthetic utility. They can undergo various reactions, such as ring-opening reactions, that allow for the formation of new carbon-carbon bonds and the synthesis of complex molecules. Cyclopropanes have also been used as anesthetics, although their use in this application has declined due to safety concerns.

Phosphodiesterase inhibitors (PDE inhibitors) are a class of drugs that work by blocking the action of phosphodiesterase enzymes, which are responsible for breaking down cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), two crucial intracellular signaling molecules.

By inhibiting these enzymes, PDE inhibitors increase the concentration of cAMP and cGMP in the cells, leading to a variety of effects depending on the specific type of PDE enzyme that is inhibited. These drugs have been used in the treatment of various medical conditions such as erectile dysfunction, pulmonary arterial hypertension, and heart failure.

Examples of PDE inhibitors include sildenafil (Viagra), tadalafil (Cialis), vardenafil (Levitra) for erectile dysfunction, and iloprost, treprostinil, and sildenafil for pulmonary arterial hypertension. It's important to note that different PDE inhibitors have varying levels of selectivity for specific PDE isoforms, which can result in different therapeutic effects and side effect profiles.

... a new selective bronchodilator agent". The Journal of Pharmacology and Experimental Therapeutics. 189 (1): 167-84. PMID 4823290 ...
As a bronchodilator after beta-agonist and anticholinergic agents have been tried, e.g. in severe exacerbations of asthma. ... but has been shown to be an ineffective tocolytic agent. More common side effects from magnesium include upset stomach and ...
... long-acting bronchodilators, beta-2 agonists, anticholinergic agents, oral steroids, antibiotics, mucolytic agents, oxygen ... Medications may be used in the process of pulmonary rehabilitation including: anti-inflammatory agents (inhaled steroids), ...
Sathe NA, Krishnaswami S, Andrews J, Ficzere C, McPheeters ML (July 2015). "Pharmacologic Agents That Promote Airway Clearance ... The bronchodilators are divided into short- and long-acting groups. Short-acting bronchodilators are used for relief of ... Bronchodilators may be originating naturally within the body, or they may be medications administered for the treatment of ... Bronchodilators are either short-acting or long-acting. Short-acting medications provide quick or "rescue" relief from acute ...
... wakefulness-promoting agents, bronchodilators, decongestants, antidepressants, entactogens, and psychedelics, among others. ...
Bronchodilators, Catecholamines, Norepinephrine releasing agents, Phenylethanolamines, Sympathomimetics, All stub articles, ... Sympatholytic Agents. VI. The Two Kinds of Receptors". Screening Methods in Pharmacology. New York: Academic Press Inc. p. 150 ... Norepinephrine David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630- ... CHRISTENSEN JM, VALASEK FE, TAINTER ML (June 1958). "Ethylnorepinephrine; a unique bronchodilator". American Practitioner and ...
Magnesium sulfate may be used as bronchodilator after beta-agonist and anticholinergic agents have been tried, e.g. in severe ... Magnesium sulfate may be used as an antiarrhythmic agent for torsades de pointes in cardiac arrest under the ECC guidelines and ...
... followed by death allowing for evaluation of novel cytoprotective agents. Potential tissue reparative agents can be evaluated ... Corticosteroids are sometimes administered, and bronchodilators to treat bronchospasms. Drugs that reduce the inflammatory ... Other inhaled agents may be directly toxic (e.g. cyanide, carbon monoxide), or cause harm simply by displacing oxygen and ... These agents are less likely to produce early warning signs (phosgene in low concentrations has a pleasant odor), are more ...
... nasal decongestants and bronchodilators (e.g., pseudoephedrine), antidepressants (e.g. bupropion), antiparkinson agents (e.g., ... bronchodilators, decongestants, and/or antidepressants, among others. Phenethylamine is produced by a wide range of species ... Norepinephrine-dopamine releasing agents, Stimulants, TAAR1 agonists, Trace amines, VMAT inhibitors). ...
It was investigated as a bronchodilator but was never marketed. C.R. Ganellin; David J. Triggle (21 November 1996). Dictionary ... of Pharmacological Agents. CRC Press. pp. 1619-. ISBN 978-0-412-46630-4. World Health Organization (1988). International ... Brunner A, Gartmann J, Studler H. "Pipoxizine, a New Bronchodilator". Lung. 154 (2): 143. Neukirch F, Korobaeff M, Verdier F, ... Bronchodilators, Ethers, H1 receptor antagonists, Benzhydryl compounds, Piperidines, Serotonin receptor antagonists, ...
It is classified by the World Anti-Doping Agency as an anabolic agent, not as a β2 agonist. Clenbuterol is prescribed for ... People with chronic breathing disorders such as asthma use this as a bronchodilator to make breathing easier. It is most ... As of 2011, the World Anti-Doping Agency (WADA) listed Clenbuterol as an anabolic agent, despite the fact there is no evidence ... Clenbuterol is approved for use in some countries as a bronchodilator for asthma.[medical citation needed] Clenbuterol is a β2 ...
Masking agents, on the other hand, work by making drug tests ineffective, leading to false-negative results. Desmopressin, ... Beta-2 agonists can act as bronchodilators and increase heart rates, in addition to their mild androgenic effects. Other banned ... This is the complete list of exogenous (non-natural) androgenic agents banned as of January 1st, 2012: Drugs with similar ... Banned androgenic agents are either anabolic steroids, which increase testosterone and epitestosterone, thereby improving ...
Analgesic agents (e.g., nitrous oxide (medication)) Platelet inhibitors Epinephrine (intramuscular) Bronchodilators (inhaled or ... Anti-hypoglycemic agents (intramuscularly or intranasally) Oral analgesics Acetylsalicylic acid EMA FRs may also be endorsed to ...
... as a bronchodilator in the treatment of asthma, preventing eclampsia and cerebral palsy, a tocolytic agent, and as an ...
... antiparkinson agents (e.g., selegiline), and vasopressors (e.g., ephedrine), among others.[medical citation needed] Many of ... nasal decongestants and bronchodilators (e.g., levomethamphetamine and pseudoephedrine), antidepressants (e.g. bupropion and ...
... anti-asthmatic agents MeSH D27.505.954.796.050.100 - bronchodilator agents MeSH D27.505.954.796.090 - antitussive agents MeSH ... bronchoconstrictor agents MeSH D27.505.696.663.050.110 - bronchodilator agents MeSH D27.505.696.663.050.225 - emetics MeSH ... antiviral agents MeSH D27.505.954.122.388.077 - anti-retroviral agents MeSH D27.505.954.122.388.077.088 - anti-hiv agents MeSH ... tocolytic agents MeSH D27.505.954.016 - anti-allergic agents MeSH D27.505.954.122 - anti-infective agents MeSH D27.505.954.122. ...
... celecoxib Other agents: Hydroxychloroquine (an antimalarial agent), diltiazem (a calcium channel blocker), omeprazole (a proton ... inhibitor), clenbuterol (a decongestant, bronchodilator), hydroxyzine (An antihistamine medication), and clopidogrel (an ... The remaining cases of AGEP have been associated with infective and other agents. The most frequently reported drugs that have ... causative agent of chicken pox). Several tests have been proposed to be useful for supporting the diagnosis of and/or ...
Short-acting bronchodilators have an effect for four hours and for maintenance therapy long acting bronchodilators with an ... Both types of agent appear to reduce the risk of acute exacerbations by 15-25%. The combination of LABA/LAMA may reduce COPD ... Bronchodilators came into use in the 1960s following a promising trial of isoprenaline. Further bronchodilators, such as short- ... Inhaled short-acting bronchodilators are the primary medications used on an as needed basis; their use on a regular basis is ...
A bronchodilator is also given in certain circumstances and a pre/post graph comparison is done to assess the effectiveness of ... or with a pharmaceutical agent such as methacholine or histamine. To assess the reversibility of a particular condition, a ... This is commonly referred to as a reversibility test, or a post bronchodilator test (Post BD), and is an important part in ... the bronchodilator. See the example printout. Functional residual capacity (FRC) cannot be measured via spirometry, but it can ...
A trial of bronchodilators should be considered in LAM patients, because up to 17-25% have bronchodilator-responsive airflow ... Agents that antagonize the effects of estrogen have not been proven to be effective for treatment, but no proper trials have ... Approximately 25% of patients with obstructive physiology may demonstrate bronchodilator responsiveness but may be less in more ...
... aluminum hydroxide Atopiclair topical emollient Benziq topical acne agent benzoyl peroxide Benziq Wash topical acne agent ... Estrasorb estrogen estradiol Maxair adrenergic bronchodilator inhaler pirbuterol Medihaler-Epi adrenergic bronchodilator, ...
... (trade names Oxivent, Tersigan) is an anticholinergic used as a bronchodilator for the treatment of asthma ... Restrepo RD (July 2007). "Use of inhaled anticholinergic agents in obstructive airway disease". Respiratory Care. 52 (7): 833- ... Bronchodilators, Muscarinic antagonists, Quaternary ammonium compounds, Epoxides, Bromides, All stub articles, Respiratory ...
Warren JB, Dalton N (May 1983). "A comparison of the bronchodilator and vasopressor effects of exercise levels of adrenaline in ... or to identify the causative agent in a potential poisoning victim. Endogenous plasma adrenaline concentrations in resting ... Bronchodilators, Carbonic anhydrase activators, Cardiac stimulants, Catecholamines, Hormones of the hypothalamus-pituitary- ... adrenal axis, Hormones of the suprarenal medulla, Neurotransmitters, Norepinephrine releasing agents, Stress (biology), ...
Bronchodilators Improving a horse's "wind" by opening its airways through the use of bronchodilators may also improve ... The widely used tranquilizer acepromazine, and any number of related or equivalent agents, have been used in this way. Higher ... Some bronchodilators can also have a stimulant effect. Behavioral modifiers Veterinarians certify horses as being sound in " ... bronchodilators, and tranquilizers with impunity. In 1988 ELISA testing was introduced to racing by a group at the University ...
Additionally, there are adverse effects to the use of bronchodilators in children such as tachycardia and tremors, as well as ... This is most commonly caused by respiratory syncytial virus (RSV, also known as human pneumovirus). Other agents that cause ... However, there are conflicting recommendations about the use of a trial of a bronchodilator, especially in those with history ... Guidelines recommend against the use of bronchodilators in children with bronchiolitis as evidence does not support a change in ...
In the inter-war period, the first anti-bacterial agents such as the sulpha antibiotics were developed. The Second World War ... Bronchodilators, antitussives, mucolytics, decongestants, inhaled and systemic corticosteroids, beta2-adrenergic agonists, ... These were drugs that worked chiefly as anti-anxiety agents and muscle relaxants. The first benzodiazepine was Librium. Three ... Antifungal, alkalinizing agents, quinolones, antibiotics, cholinergics, anticholinergics, antispasmodics, 5-alpha reductase ...
The derivative N,N-ethylenebis(stearamide) (EBS) is a commercially significant mold-release agent and a surfactant in gasoline ... Ethylenediamine is an ingredient in the common bronchodilator drug aminophylline, where it serves to solubilize the active ... A most prominent derivative of ethylenediamine is the chelating agent EDTA, which is derived from ethylenediamine via a ... chemicals for color photography developing, binders, adhesives, fabric softeners, curing agents for epoxies, and dyes. as a ...
However, there is little evidence to support prokinetic agents are an appropriate treatment for dyspepsia. Currently, PPIs are ... bronchodilators (theophylline), diabetes drugs (acarbose, metformin, Alpha-glucosidase inhibitor, amylin analogs, GLP-1 ... prokinetic agents, and antiflatulents. PPIs and H2-RAs are often first-line therapies for treating dyspepsia, having shown to ... cholesterol-lowering agents (niacin, fibrates), neuropsychiatric medications (cholinesterase inhibitors [donepezil, ...
Although agents more selective for PDE5 were in development, these trials have been suspended, likely due to the saturation of ... We now know that this was due to the bronchodilator properties of caffeine, a non-selective, albeit weak, PDE5 inhibitor. In ... Other agents with weak PDE5 inhibitory properties include Zaprinast and icariin. Although all PDE5 inhibitors share the same ... The occurrence of side effects, or adverse drug reactions (ADRs), with PDE5 inhibitors depends on the dose and type of agent. ...
General anesthetic agents, opioids, and neuromuscular-blocking drugs may diminish or even abolish the respiratory drive. ... They may also be used as a route for administration of certain medications such as bronchodilators, inhaled corticosteroids, ... Spontaneous ventilation has been traditionally performed with an inhalational agent (i.e. gas induction or inhalational ... and several apparati for the administration of volatile anesthetic agents. The Magill curve of an endotracheal tube is also ...
Antiviral Agents. Class Summary. Influenza vaccinations offer greater protection for the appropriate populations because they ... Bronchodilators. Class Summary. Studies (although limited) have shown an advantage to using bronchodilators and possible ... This agent inhibits bacterial protein synthesis by binding with the 30S and, possibly, the 50S ribosomal subunit(s). It is less ... Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2010 Feb 17. 2: ...
Short Acting Adrenergic Bronchodilator Agents essay example for your inspiration. ✔️ 2451 words. ✍ Read and download unique ... Home / Health Care / Asthma / Short Acting Adrenergic Bronchodilator Agents. Short Acting Adrenergic Bronchodilator Agents. ... Short Acting Adrenergic Bronchodilator Agents. These medications are also known as short-acting beta-agonists (SABAs). SABAs ... The short acting adrenergic bronchodilator agents are available in four forms namely pills, injectable, inhaler, and liquids ( ...
The Linked Data Service provides access to commonly found standards and vocabularies promulgated by the Library of Congress. This includes data values and the controlled vocabularies that house them. Datasets available include LCSH, BIBFRAME, LC Name Authorities, LC Classification, MARC codes, PREMIS vocabularies, ISO language codes, and more.
Anti-Asthmatic Agents - Bronchodilator Agents PubMed MeSh Term *Overview. Overview. broader concept * Anti-Asthmatic Agents ...
... the effects of two inhaled bronchodilators, salbutamol (beta 2-agonist) and ipratropium bromide (muscarinic blocker), were ... Bronchodilator Agents / therapeutic use* * Bronchopulmonary Dysplasia / drug therapy* * Bronchopulmonary Dysplasia / ... Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease J Pediatr. 1987 Aug; ... Nebulized saline solution had no bronchodilator effect in five infants. These results suggest that in infants with early and ...
Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the ...
Immediate Release Products. The patient (or parent/care giver) should be instructed to seek medical advice whenever nausea, vomiting, persistent headache, insomnia or rapid heart beat occurs during treatment with theophylline, even if another cause is suspected. The patient should be instructed to contact their clinician if they develop a new illness, especially if accompanied by a persistent fever, if they experience worsening of a chronic illness, if they start or stop smoking cigarettes or marijuana, or if another clinician and a new medication or discontinues a previously prescribed medication. Patients should be instructed to inform all clinicians involved in their care that they are taking theophylline, especially when a medication is being added or deleted from their treatment. Patients should be instructed to not alter the dose, timing of the dose, or frequency of administration without first consulting their clinician. If a dose is missed, the patient should be instructed to take the ...
Mucolytic Agents. Class Summary. Large amounts of neutrophil-derived DNA released from dead neutrophils increase sputum ... Bronchodilators. Class Summary. Albuterol provides selective agonistic action on beta2-adrenoceptors. Stimulation of adenyl ... This agent inhibits bacterial DNA synthesis and, consequently, growth. Oral bioavailability is lower in younger patients with ... These agents aid digestion when the pancreas is malfunctioning. Current pancreatic enzyme preparations are derived from porcine ...
bronchodilator agent An agent that causes an increase in the expansion of a bronchus or bronchial tubes. ... nitric oxide (CHEBI:16480) has role bronchodilator agent (CHEBI:35523) nitric oxide (CHEBI:16480) has role human metabolite ( ... nitric oxide (CHEBI:16480) has role vasodilator agent (CHEBI:35620) nitric oxide (CHEBI:16480) is a inorganic radical (CHEBI: ... vasodilator agent A drug used to cause dilation of the blood vessels. ...
Bronchodilator Agents / immunology * Bronchodilator Agents / pharmacology * Bronchodilator Agents / therapeutic use* * Gene ...
Bronchodilator agents. Cholinergic antagonists. Cystic fibrosis/therapy. Lung volume measurements. Plethysmography. Respiratory ... The functional effect of long-acting anticholinergic agents in patients with cystic fibrosis (CF) is still unknown, despite the ...
Pharmacological Actions : Bronchodilator Agents. [+] Inhibitory effect of Portulaca oleracea L. aqueous extract and juice on ... Pharmacological Actions : Anti-Inflammatory Agents, Antioxidants, Hypoglycemic Agents. Additional Keywords : Anti-Obesity ... P. oleracea extract is a general tissue protective and regenerative agent and may be a novel therapeutic agent for diabetes ... Pharmacological Actions : Anti-Inflammatory Agents, Hepatoprotective, Hypoglycemic Agents, Hypolipidemic, Interleukin-1 beta ...
... a new selective bronchodilator agent". The Journal of Pharmacology and Experimental Therapeutics. 189 (1): 167-84. PMID 4823290 ...
information about asthma medications (bronchodilators and anti-inflammatory agents);. *use of inhalers and peak flow meters; ...
LR: 20151119; JID: 101273481; 0 (Bronchodilator Agents); 0 (Tobacco Smoke Pollution); OID: NLM: PMC3794890; OTO: NOTNLM; 2013 [ ... Using spirometric measurements before and after the use of inhaled bronchodilators, we tracked the frequency of CRD in females ... Opioid (narcotic) antagonists are of particular interest to investigators as potential agents to attenuate the rewarding ... LR: 20160602; JID: 100909747; 0 (Alkaloids); 0 (Antidepressive Agents, Second-Generation); 0 (Azocines); 0 (Benzazepines); 0 ( ...
Categories: Bronchodilator Agents Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
Respiratory agents, used primarily in the management of asthma, included bronchodilators and leukotriene modifiers. ... The most common medications were respiratory agents and psychotherapeutic agents. ... Psychotherapeutic agents included CNS stimulants and antidepressants, which are associated with rare but serious adverse ...
Anderson GP: Pharmacology of formoterol: an innovative bronchodilator. Agents Actions Suppl. 34:97-115. 1991.PubMed/NCBI ...
Bronchodilator Agents Medicina y ciencias biológicas 43% * Phytochemicals Medicina y ciencias biológicas 41% ... keywords = "Bronchodilator activity, Huanarpo female, Jatropha macrantha",. author = "Haydee Ch{\a}vez and Freddy Palomino and ... Aims: To evaluate the in vivo bronchodilator activity of the ethanolic extract of the stems of J. macrantha. Methods: The ... Aims: To evaluate the in vivo bronchodilator activity of the ethanolic extract of the stems of J. macrantha. Methods: The ...
These effects completely reversed after the bronchodilator agent albuterol was administered, and an improvement compared with ... this effect completely reversed after the bronchodilator agent albuterol was administered, and an improvement compared with ... In a study by Kee et al of bronchoeffector agents, the appearance of the airways on HRCT scans showed that airway internal ... A later study demonstrated similar reversibility in patients receiving the bronchodilator albuterol (see the images below). [74 ...
Beta-blockers, especially non-cardioselective agents, also antagonise the cardiac and bronchodilator effects of adrenaline. ... Antidepressant agents: Tricyclic antidepressants such as imipramine, inhibit reuptake of directly acting sympathomimetic agents ... Beta-adrenergic blocking agents: Severe hypertension and reflex bradycardia may occur with non-selective beta-blocking drugs ... Do not mix with other agents unless compatibility is known.. The patient should be monitored as soon as possible (pulse, blood ...
... in which case the use of bronchodilators that are known cardiac sensitizing agents may pose enhanced risk. ... in which case the use of bronchodilators that are known cardiac sensitizing agents may pose enhanced risk. ... in which case the use of bronchodilators that are known cardiac sensitizing agents may pose enhanced risk. ... Treat patients who have bronchospasm with an aerosolized bronchodilator such as albuterol. Consider that barium poisoning may ...
Meanwhile, pharmaceutical development is also noticeable, manifesting in novel bronchodilators and anti-inflammatory agents. ... Preeminent among these are bronchodilators, which work by relaxing the muscles of the airways, and corticosteroids, which help ...
a. Mineralization/bacteriostatic agents* "obturator". i. Has alkaline pH, slow release of Ca ions, induces pulp cell ...
Combining short-acting bronchodilator agents (salbutamol (albuterol)/ipratropium) produces a greater change in spirometry than ... Bronchodilators. Three types of bronchodilator are in common clinical use: β‐agonists, anticholinergic drugs and ... Combining different agents produces a greater change in spirometry and symptoms than single agents alone. ... Short-acting bronchodilators can increase exercise tolerance acutely 30, 31. Long-acting inhaled β‐agonists improve health ...
Drug treatment of asthma consists of symptom controllers such as bronchodilators and anti-inflammatory agents (e.g., ... or stem-cell transplant recipients or those receiving cancer chemotherapy agents, corticosteroids, or other agents inhibiting ... For biologic agents, few biomarkers of exposure or dose have been identified, and their validity for exposure assessment in the ... Detection of immunoglobulin G (IgG) to specific fungi has been used as a marker of exposure to agents that might cause ...
Atrovent and other anticholinergic agents are bronchodilators which could help with opening up the airways in people with ... Anticholinergic agents block bronchoconstriction mediated by the vagus nerve and may also dry up bronchial secretions. They are ...
Bronchodilator + Bronchial Anti-Inflammatory + Anti-inflammatory agent Active Ingredient Budesonide + Formoterol Line. Medical ...
  • If the symptoms persist, this is an indication of poorly controlled asthma, and allergist / immunologist should be consulted to adjust prescription for the long acting bronchodilator since they are suitable for constant regulation and control of asthma symptoms ("Short-Acting Beta2-Agonists for Quick Relief of Asthma Symptoms", 2015). (essaywriter.org)
  • The medication should be used as a bronchodilator for bronchial asthma and emphysema and bronchitis which occurs due to reversible bronchospasm. (essaywriter.org)
  • Respiratory agents, used primarily in the management of asthma, included bronchodilators and leukotriene modifiers. (sciencedaily.com)
  • If your lung function improves with use of a bronchodilator, it's likely you have asthma. (mayoclinic.org)
  • Conclusions --The patient populations receiving care for asthma vary (anti-inflammatory agents) or open the depending on the ambulatory care setting. (cdc.gov)
  • Patients relying on hospital outpatient airways by relaxing bronchial smooth care for chronic asthma conditions may receive differential treatment and have muscles (bronchodilator drugs). (cdc.gov)
  • Therapies for asthma have generally minimized or excluded the use of anticholinergic agents. (medscape.com)
  • It has been known for many years that anticholinergic agents are effective bronchodilators for asthma and COPD , although they are less potent than beta-agonists in the management of asthma. (medscape.com)
  • [ 2 ] A recent clinical trial shows that tiotropium bromide is an effective long-term asthma therapy and could be considered the treatment of choice if adrenergic agents are deemed inappropriate. (medscape.com)
  • Physiologic assessment of occupational asthma was discussed including pulmonary function tests with and without bronchodilator treatment, spirometry before and after work shifts, ambulatory monitoring of peak expiratory flow rates over several weeks, and bronchial provocation with nonspecific agents such as histamine or methacholine. (cdc.gov)
  • Atrovent and other anticholinergic agents are bronchodilators which could help with opening up the airways in people with bronchiectasis. (cochrane.org)
  • Anticholinergic agents block bronchoconstriction mediated by the vagus nerve and may also dry up bronchial secretions. (cochrane.org)
  • The recommended pharmacotherapy for the treatment of COPD is generally bronchodilators ( β 2 agonists and long-acting anticholinergic agents) in patients with mild disease [ 15 , 16 ]. (hindawi.com)
  • Patients were excluded if they had reversible airway disease, an indication needing bronchodilator therapy. (elsevierpure.com)
  • Airway hyperresponsiveness, an exaggerated bronchospastic response to nonspecific agents such as methacholine and histamine or specific antigens, is the physiologic cornerstone of this disorder. (jci.org)
  • Initial exposure to type 1 agents causes sneezing, coughing, and spasm of the windpipe, which can block the airway. (msdmanuals.com)
  • The paper is geared at the compressive analysis of three short acting adrenergic bronchodilator agents namely Metaproterenol, Albuterol, and Levalbuterol. (essaywriter.org)
  • Albuterol is the most commonly used bronchodilating agent. (medscape.com)
  • Lung function tests often are done before and after taking a medication to open your airways called a bronchodilator (brong-koh-DIE-lay-tur), such as albuterol. (mayoclinic.org)
  • Metaproterenol sulfate belongs to a class of medication known as bronchodilator which functions to relax the smooth muscles of bronchial opening up the airways into the lung ("Alupent (Metaproterenol Sulfate): Side Effects, Interactions, Warning, Dosage & Uses", 2017). (essaywriter.org)
  • An agent that causes an increase in the expansion of a bronchus or bronchial tubes. (ebi.ac.uk)
  • A Bronchodilators' main job is to open up the airways by relaxing the bronchial smooth muscles. (jaxmed.com)
  • The long-acting inhaled bronchodilators available for use in chronic obstructive pulmonary disease (COPD) vary in their pharmacological class (β2-adrenergic agonist or antimuscarinic/anticholinergic, alone or combined), durations of action and speed of onset of bronchodilator effect. (elsevierpure.com)
  • The move towards increasing duration of bronchodilator action is generally paralleled by improved effects on clinical outcomes, and the advent of more potent agents seems likely to provide an opportunity to reduce overreliance on the use of inhaled corticosteroids in treating COPD. (elsevierpure.com)
  • All three of these long-acting, single-agent bronchodilators are recommended for use as first-line maintenance treatment of moderate COPD. (rtmagazine.com)
  • COPD was defined together with post-bronchodilator airflow obstruction and the presence of respiratory symptoms. (sdu.dk)
  • Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis. (pharmacycode.com)
  • Pulmonary function testing before and after bronchodilators is suggested to avoid these counterproductive effects. (medscape.com)
  • Pulmonary agents affect the lungs and airways. (msdmanuals.com)
  • Current guidelines [ 1 ] mention ipratropium , a short-acting anticholinergic agent, in the context of short-term relief, but until very recently, the list of long-term controllers did not include tiotropium bromide, the only long-acting anticholinergic agent. (medscape.com)
  • The two types of bronchodilators are beta-adrenergic agonists (beta2 agonists) and methylxanthines (theophylline). (jaxmed.com)
  • Beta -adrenergic agonists, 2 inflammatory agents. (cdc.gov)
  • The preferred bronchodilator has changed from methylxanthines, and anticholinergics methylxanthines to beta -adrenergic agonists. (cdc.gov)
  • Atenolol, USP, a synthetic, beta 1 -selective (cardioselective) adrenoreceptor blocking agent, may be chemically described as 2-[p-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide. (nih.gov)
  • Atenolol is a beta 1 -selective (cardioselective) beta-adrenergic receptor blocking agent without membrane stabilizing or intrinsic sympathomimetic (partial agonist) activities. (nih.gov)
  • smooth muscle relaxation (i.e., bronchodilation) and suppression of the response of the airways to stimuli (i.e., non-bronchodilator prophylactic effects). (pharmacycode.com)
  • Quick-relief inhalers (bronchodilators) quickly open swollen airways that are limiting breathing. (mayoclinic.org)
  • Mixed-effect agents can affect large airways, small airways, and the alveoli. (msdmanuals.com)
  • Mixed-effect agents act in both large airways and alveoli in low to moderate doses. (msdmanuals.com)
  • Using a noninvasive passive flow volume technique to measure respiratory system resistance (Rrs) and compliance (Crs), the effects of two inhaled bronchodilators, salbutamol (beta 2-agonist) and ipratropium bromide (muscarinic blocker), were studied in 17 premature infants ranging in age from 19 to 103 days. (nih.gov)
  • The most common medications were respiratory agents and psychotherapeutic agents. (sciencedaily.com)
  • This report updates the 2004 recommendations by the Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. (cdc.gov)
  • The Metaproterenol should not be used with other beta adrenergic aerosol bronchodilators as it can result in additive effects. (essaywriter.org)
  • Children with bronchiectasis may have a paradoxic bronchodilatation in response to beta-adrenergic agents. (medscape.com)
  • Showing these signs and symptoms does not necessarily mean that a person has been exposed to riot control agents. (cdc.gov)
  • If symptoms go away soon after a person is removed from exposure to riot control agents, long-term health effects are unlikely to occur. (cdc.gov)
  • People with an initially noisy chest and prominent symptoms were likely exposed to a type 1 agent. (msdmanuals.com)
  • The review begins with the evidence on the effectiveness of cannabinoids as anti-emetic drugs for nausea caused by cancer chemotherapy, and as agents to control intra-ocular pressure in glaucoma. (druglibrary.net)
  • are types of bronchodilator drugs. (cdc.gov)
  • Briefer reviews are provided of the evidence in favour of other putative therapeutic uses of cannabinoids which are less well supported by clinical evidence, chief among which are its uses as an anti-convulsant, an anti-spasmodic, and an analgesic agent. (druglibrary.net)
  • These medications include anti-inflammatory agents and bronchodilators. (jaxmed.com)
  • Bronchodilators and anti-inflammatory environmental irritants, viral infections, agents were the most common medications prescribed. (cdc.gov)
  • Aims: To evaluate the in vivo bronchodilator activity of the ethanolic extract of the stems of J. macrantha. (edu.pe)
  • Profundice en los temas de investigación de 'Evaluación broncodilatadora in vivo del extracto etanólico de los tallos de Jatropha macrantha Müll.Arg. (edu.pe)
  • HRCT has the potential to aid with the functional assessment of the lungs, such as tests of airtrapping and the bronchodilator response. (medscape.com)
  • Anti-inflammatory agents prevent or stop the further development of inflammation in the lungs. (jaxmed.com)
  • In the early stages of development of a maintenance bronchodilator, the goals are to identify a molecule with the theoretically 'ideal' profile of fast onset and prolonged duration of action in comparison with existing agents, while minimizing non-specific activity at organs outside the lungs. (elsevierpure.com)
  • Riot control agents (sometimes referred to as "tear gas") are chemical compounds that temporarily make people unable to function by causing irritation to the eyes, mouth, throat, lungs, and skin. (cdc.gov)
  • Best and safe treatment for this condition is inhaled bronchodilators which is asthalin and anti inflammatory agents which is budecort. (ndtv.com)
  • However, with high doses of type 1 agents, delayed-onset chest tightness or shortness of breath (type 2 effects) may also occur. (msdmanuals.com)
  • Neurotoxicity agent of the jaw that causes jaw pain in patient? (brainscape.com)
  • Patient data were obtained using the University Health System Consortium Clinical Data Base/Resource Manager (Chicago, IL) to compare outcomes during two 6-month periods separated by a 4-month intervention phase aimed to reduce bronchodilator use. (elsevierpure.com)
  • Materials and methods: Subjects were included in the analysis if they were aged more than 18 years, on mechanical ventilation in the intensive care unit, and received aerosolized bronchodilators. (elsevierpure.com)
  • Antimicrobial agents were the most commonly prescribed followed by NSAIDs/analgesics. (who.int)
  • These results suggest that in infants with early and late chronic lung disease, bronchospasm can be partially alleviated by inhaled bronchodilators. (nih.gov)
  • Several different compounds are considered to be riot control agents. (cdc.gov)
  • Riot control agents are used by law enforcement officials for crowd control and by individuals and the general public for personal protection (for example, pepper spray). (cdc.gov)
  • Because they are liquids or solids (for example, powder), riot control agents such as CN and CS could be released in the air as fine droplets or particles. (cdc.gov)
  • The extent of poisoning caused by riot control agents depends on the amount of riot control agent to which a person was exposed, the location of exposure (indoors versus outdoors), how the person was exposed, and the length of time of the exposure. (cdc.gov)
  • Riot control agents work by causing irritation to the area of contact (for example, eyes, skin, nose) within seconds of exposure. (cdc.gov)
  • Since inhalation is likely to be the primary route of exposure, leave the area where the riot control agents were released and get to fresh air. (cdc.gov)
  • Quickly moving to an area where fresh air is available is highly effective in reducing exposure to riot control agents. (cdc.gov)
  • If the riot control agents were released outdoors, move away from the area where the agents were released. (cdc.gov)
  • Go to the highest ground possible, because riot control agents will form a dense vapor cloud that can travel close to the ground. (cdc.gov)
  • If the release of riot control agents was indoors, get out of the building. (cdc.gov)
  • Psychotherapeutic agents included CNS stimulants and antidepressants, which are associated with rare but serious adverse effects like thoughts of suicide, serotonin syndrome and even sudden death. (sciencedaily.com)
  • The effects of exposure to a riot control agent are usually short-lived (15-30 minutes) after the person has been removed from the source and decontaminated (cleaned off). (cdc.gov)
  • 8.2 Cannabinoids as anti-emetic agents Profound nausea and vomiting can be such serious complications of chemotherapy and radiotherapy for cancer that patients may discontinue potentially life-saving treatment (Institute of Medicine, 1982). (druglibrary.net)
  • For example, its value as an anti-emetic agent in the treatment of nausea caused by cancer chemotherapy seems to have been rediscovered by young adults who had used cannabis recreationally prior to undergoing chemotherapy for leukemia (Grinspoon, 1990). (druglibrary.net)
  • Conclusions: The results showed bronchodilator activity of the ethanolic extract of J. macrantha at an average dose of 400 mg/kg, orally, in Cavia porcellus. (edu.pe)
  • However, as has been shown for all beta-blocking agents, the antihypertensive effect does not appear to be related to plasma level. (nih.gov)
  • The office visit rate in exaggerated broncho-constrictor the Northeast was almost 2.5 times that in the South, although the prevalence of response to many physical changes and chemical and pharmacologic agents. (cdc.gov)
  • Conclusions: Multimodal efforts to restrict aerosolized bronchodilator therapy in mechanically ventilated patients were successful and led to sustained reductions in use that was associated with substantial reductions in cost, without affecting LOS. (elsevierpure.com)
  • If you think you may have been exposed to riot control agent, you should remove your clothing, rapidly wash your entire body with soap and water, and get medical care as quickly as possible. (cdc.gov)
  • It is usually well tolerated and provides good coverage of most infectious agents, but it is not effective against Mycoplasma and Legionella species. (medscape.com)
  • Amoxicillin alone or in combination was the most commonly prescribed antimicrobial agents followed by cefuroxime. (who.int)
  • Avoid dense, low-lying clouds of riot control agent vapor. (cdc.gov)
  • If you are near a release of riot control agent, emergency coordinators may tell you to either evacuate the area or "shelter in place" inside a building to avoid being exposed to the chemical. (cdc.gov)
  • Purpose: The purpose of this evaluation is to describe the cost savings associated with multimodal interventions aimed at reducing aerosolized bronchodilator use in mechanically ventilated patients without adversely affecting costs associated with length of stay (LOS). (elsevierpure.com)
  • Based on whole acquisition costs, the total cost of bronchodilators dispensed to the adult intensive care units over the 6-month postintervention phase was reduced by $56. (elsevierpure.com)
  • Overview of Chemical-Warfare Agents Chemical weapons are developed by governments for wartime use and include Toxic agents (intended to cause serious injury or death) Incapacitating agents (intended to cause only temporary, non-life-threatening. (msdmanuals.com)
  • Quickly take off clothing that may have riot control agent on it. (cdc.gov)